







ROLE FOR THE ESCRT COMPLEX IN THE RELATIONSHIP 








A thesis submitted to Johns Hopkins University in conformity with the requirements for 
















Nutrient sensing is a vital cellular pathway used by all organisms to synchronize 
their cellular proliferation to correspond with their nutritional status through TOR (target 
of rapamycin) regulation. Therefore, when cells sense a low nutrient environment, 
cellular proliferation is halted and autophagy is initiated. Autophagy is a protective 
mechanism to allow cells to recycle, self-eat, their expended organelles for energy and 
survival. The relationship between nutrient sensing and autophagy is imperative for 
proper cellular growth, and when defective, can result in detrimental onset of various 
diseases. Results of a high-throughput screening of the yeast knockout collection of 
Saccharyomyces cerevisiae by Teng and the Hardwick lab identified knockout strains 
that lack components of the ESCRT pathway, which is conserved from yeast to 
mammals, resulted in a growth phenotype in low amino acid medium. These knockout 
strains failed to halt proliferation in low amino acid conditions, thus proceeded to 
outgrow wild type. Yeast screen also revealed a group of strains expressed phenotypes 
derived from a secondary mutation, rather than the original knockout gene.  Although, 
tetrad dissections I executed on the ESCRT knockout strains confirmed the opposite, 
phenotypes were derived from the original knockout gene and were not due to a 
secondary mutations. This knowledge allows for a direct extrapolation of experimental 
results to be directly related to the gene deletions itself.  
ESCRTs dynamic ability to curve membranes and create multivesicular bodies 
provides exceptional functionality and mobility for various cellular mechanisms. I 
hypothesize that there are more ESCRT functions to be uncovered. I propose that the 
multivesicular body biogenesis provides an excellent vehicle to relay nutrient signals to 
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properly correlate cell growth with its external and internal environments. When 
correlation is dysregulated improper cell growth occurs under nutrient improvished 
conditions. My research further investigated the phenotypes of ESCRT strains in relation 
to TOR and autophagy under nutrient deprivation reveals new insights into ESCRT 
functions. Evidence show ESCRT protein expression of subcomplexes I and III expressed 
a defect in TOR kinase regulatory activity due to the maintenance of Tor activity, and or 
increasing Tor activity during times of nutrient withdrawal. My data suggest new 
functions of yeast ESCRTs by possibly conveying nutrient signaling through 
multivesicular bodies.  My studies on nutrient signaling emphasizes the critical role of 
this vital pathway for cellular organisms, and when defective can be detrimental to a 
cell’s ability to effectively sustain life. Defects in TOR can lead to accelerated aging, 
cancer, and epilepsy. The links between ESCRTs, nutrient signaling, and human health 
are only just the beginning to be uncovered.  
 
 
Dr. J. Marie Hardwick, Professor and Thesis Advisor  
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Target of Rapamycin  
Introduction  
Yeast and mammalian cells have the ability to sense and adapt to the nutrient 
levels in the external and internal environment, and these process are vital to their 
survival. The ability and criticality of cells accessing their nutrient levels is important to 
adjust many cellular physiology processes accordingly such as, metabolism, cell 
proliferation, cell development, ribosome biogenesis, and transcription1. Even though 
yeast are unicellular eukaryotes, yeast have multiple pathways similar to mammalian 
cells to sense different types of nutrients including glucose and nitrogen levels1.  Nutrient 
sensing abilities are conserved across species2. A main sensors of nutrient status is the 
target of rapamycin (TOR) pathway. TOR monitors both intra- and extracellular 
parameters and integrates the nutrient signals with cellular physiological signals  to 
properly control its downstream effector pathways such as cell size, proliferation, and life 
span3.  
TOR was discovered to be the target of a small molecule inhibitor of cell growth, 
rapamycin, by studying mutations in TOR. Mutations in FKBP-rapamycin complex in 
TOR-1 and TOR-2 in S. cerevisiae resulted in rapamycin growth resistance4. Rapamycin, 
a potent antifungal metabolite produced from Streptomyces hygroscopius, was originally 
identified as macrocyclic lactone, but was later renamed to rapamycin upon the discovery 
that it inhibits mammalian cell proliferation and has immunosuppressive properties5. 
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TOR is part of a conserved group of serine/threonine kinases from the 
phosphatidylinositol kinase-related kinase (PIKK) family3.   
Although TOR is evolutionary conserved, a remarkable difference occurs between 
the S. cerevisiae and mammals. Yeast encode two TOR genes (TOR1 and TOR2), while 
higher eukaryotes only have one TOR gene (mTOR)5–8. Although structurally similar, 
TOR1 and TOR2, their functionality is not identical9,10. In addition to controlling cellular 
growth, TOR2 also controls actin organization, endocytosis and lipid biosynthesis11. 
Thereby, TOR2 gene is mainly responsible for TORC2 function allowing TORC2 to be 
functionally different from TORC1.  
However, all TOR genes have similar domain structures, including HEAT 
repeats, FAT domain, FRB domain, kinase domain, and FATC domain12.  Heat repeats at 
the N-terminus provide a binding region for TOR complex subunits13. The FAT domain 
and FATC domain are characteristic of the PIKK family14–16. The FRB domain is 
important because it is the binding region for FKBP-rapamycin, specifically in mammals, 
the FKBP12-rapamycin complex binds the FRB domain in mTOR17,18. Biochemical 
purification revealed that TOR proteins exist in two distinct protein complexes (TORC1), 
mTORC1 and TORC2 (TORC1 and TORC2 in yeast)19. 
 
TORC1 
The yeast TORC1 complex consists of  KOG1 (mammalian, Raptor), TCO89, 
LST8 (mLst8), and either TOR1 or TOR219–24. An important characteristic of TORC1 is 
its sensitivity to rapamycin, although some targets of TORC1 are rapamycin-insensitive, 
3 
 
e.g. phosphorylation of TFEB by mTORC125,26. TORC1 depletion experiments 
uncovered a role for TORC1 in coupling nutrients with cell growth5. TORC1 positively 
regulates cell growth in response to nutrients by inducing ribosome biogenesis, 
translation, metabolism, cell survival and nutrient import, thereby increasing biomass 
accumulation3,5. In addition, TORC1 has negative regulators such as stress and starvation, 
which leads to autophagy induction3. Specific amino acids from the media are capable of 
activating TOR, L-tryptophan, L-phenylalanine, L-arginine, and especially the branched 
amino acid L-leucine27,28. However, it still remains unclear exactly how amino acid 
sufficiency is sensed. Although speculations can be based off of other known nutrient 
sensing pathways like nitrogen pathway in yeast1,29.   
The subcellular localization of TORC1 is key in its function as a nutrient sensor. 
It has been observed that TORC1 is localized on the limiting membrane of the yeast 
vacuole and mammalian lysosomes30–33. The location of TORC1 on yeast vacuoles is 
logical because the vacuole is a major nutrient reservoir29. The location of TORC1 has an 
enormous influence on its nutrient sensing capabilities.  
 
TORC2  
The yeast TORC2 protein complex is composed of AVO1 (Sin1), AVO2, AVO3, 
BIT61 (Rictor), LST8 (mLST8), and TOR2 (mTOR)19,20. Majority of TOR2 is in TORC2 
versus TORC129. Unlike TORC1, TORC2 is rapamycin-insensitive due to AVO1 
masking the FRB domain in TOR229. In addition, TORC2 is required for actin 
cytoskeletal organization (mediating spatial control of cell growth), endocytosis, and lipid 
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biosynthesis5,19,31. This function is mostly derived from having TOR2 in this complex and 
TORC2 location. TOR2 is known to be rapamycin-insensitive and is known to distinct 
have the distinct ability to control cell growth to control organization of actin 
cytoskeleton, endocytosis, and sphingolipid synthesis29. Multiple studies confirm that 
TORC2 is near/at plasma membrane29. This location is consistent with TORC2 role in 
controlling the polarization actin cytoskeleton and endocytosis29. TORC2 function 
projects its ability to mediate spatial cell growth by controlling cell-cycle-dependent 
polarization of the actin cytoskeleton to direct newly made proteins and lipids to the 
growing daughter bud29.  
AVO1 and AVO3 bind to the HEAT repeats on TOR and are required for TORC2 
integrity5.  AVO2 is a non-essential protein that may recruit additional substrates to 
TOR13,34. However, AVO2 and BIT61 are unique to yeast5. Lst8 (Gβ-like propeller 
protein) binds to the kinase domain in TOR2 and is required for TOR2 kinase 
activity13,19. Unlike TORC1, upstream regulators have not been identified. 
 
TOR is a Central Controller of Cell Growth 
In summary, cell growth is heavily dependent on the nutrients for growth 
stimulation within the cell, and TOR (TOR1 or TOR2) is essential for cell growth. TOR1 
primarily upregulates cell growth in nutrient replete conditions and TOR2 regulates the 
spatial growth via controlling polarization of actin cytoskeleton29,35.  Cells maintain high 
rates of ribosome biogenesis, translation, initiation, and nutrient import when TOR is 
active under nutrient rich conditions5. The opposite occurs when cells are starved, 
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nitrogen depleted, rapamycin-treated, and or depleted of TOR1/TOR2 resulting in a 
dramatic downregulation of protein synthesis (decreased cell growth) and an upregulation 
of macroautophagy5. In conclusion, depending on cells growth conditions, rapamycin-
sensitive TOR signaling can either promote anabolic processes or catabolic processes, 
and therefore, is influential on life span3,5.   
TORC1 is responsible for correlating nutrient sensing to ribosomal biogenesis. 
Henceforth, TORC1 promotes cellular growth under nutrient rich conditions. Mammalian 
and yeast TORC1 regulates translation via phsophorylation and activation of Sch9/S6K1 
kinase and phosphorylation and inhibition of 4E-BP5.  S6K1 belongs to the AGC family 
kinases, and therefore, requires phosphorylation of two sites to become active5. The 
activated form will phosphorylate a ribosomal protein on S6 to induce protein 
translation29.  
A well-studied kinase, Sch9, establishes the connection of TOR-dependent 
nutrient sensing to ribosome biogenesis1. Sch9, a kinase from the AGC family kinases, is 
the closest yeast homolog to mammalian TOR-regulated S6K11. Overexpression 
experiments of Sch9 reveal its dual capability of inducing ribosome biogenesis genes 
while repressing carboxylic acid metabolism genes1. In response to nutrients, TOR 
directly phosphorylates Ser/Thr sites on the C-terminus of Sch930. Under rapamycin 
treatment, carbon, or nitrogen starvation switch leads to the rapid desphosphorylation of 
Sch9, thus inhibiting translation and cell growth1. Therefore, phosphorylation of Sch9 by 
TORC1, or phosphorylation of S6 by Sch9/S6K1 is the best way to monitor TOR 
activity. Unfortunately, the exact mechanism used to relay nutrient signals to TORC1 still 
remains elusive29.  
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TOR and its relationship with nutrient sensing   
It was found that TOR alteration of yeast physiology was similar to that nutrient 
starvation, which started TORs relationship with nutrient sensing36. However, 
understanding how TORC1 senses and transduces nutrient signaling remains elusive, but 
is being actively researched. It was thought that TORC1 was the primary modulator for 
nitrogen response1. Although suggestive, further investigation concluded that TORC1 
may respond to the quality of nitrogen source and is not the sole mediator to the nitrogen 
response pathway due to is difference in reverse recovery from nitrogen deprivation and 
rapamycin treatment1. Therefore, TORC1 nutrient target still remains a mystery. One 
possibility is through the EGO complex, which shares the same location as TORC1, 
vacuolar/lysosomal membrane (Figure 1)33.  
The yeast vacuole asserts itself as the location for both TORC1 and EGO 
complex. Since the yeast vacuole is the main nutrient reservoir, EGO complex couples 
amino acid signals to TORC133.  Under unfavorable nutrient conditions, or rapamyin 
treatment, cells enter a quiescence phase (G0)29. For a cell to exit the G0 stage properly 
requires the EGO complex37. In fact, amino acid activates TORC1 through a GTPase 
heterodimer of Gtr1 and Gtr2, which are found together with Ego1 and Ego3 making up 
the EGO complex28.  Gtr1 and Grt2 act in combination to activate TORC1, but Gtr1 
interaction with TORC1 dominates over Grt233. Leucine starvation leads to 
destabilization of Grt1-TORC1 associations and results in reduced phosphorylation of 





TOR and autophagy  
TOR has the unique ability to link reactions of both cellular proliferation and 
cellular degradation (autophagy), thereby using its ability to promote both anabolic 
processes and catabolic processes3,5. Its intimate relationship with autophagy promotes 
cell survival. Autophagy functions to sequester cytosolic material and deliver to lysosome 
for degradation to provide energy from recycled materials for the cell to survive38. In 
nutrient-improvished conditions autophagy is stimulated to promote cellular survival5. 
Not only is TOR a nutrient sensor and controls cell growth, but it also controls autophagy 
in yeast and higher eukaryotes39. Yeast TORC1 regulates macroautophagy by inhibiting 
protein kinase Atg1 by phosphorylating Atg13 and preventing Atg13 from interacting 







 Autophagy is a pivotal mechanism used to counteract the pressures exerted in 
hostile environments. This protective cellular mechanism involves sequestering cytosolic 
material and delivery of cargo to lysosomes for further degradation38,43. Stress conditions 
such as starvation, organelle damage, and microbe invasion, can induce autophagy43. 
Induction is coordinated with the inhibition of cellular proliferation under an autophagy 
stimulated cellular state. Autophagy is responsible for sequestering a variety of cytosolic 
materials such as damaged organelles, cytosolic proteins, and invasive microbes43. The 
degradative products of these materials are released back into the cytosol to recycle 
protein constituents to produce energy in order to maintain cell’s viability in conditions 
of stress and provide protection for cells44,45.  
There are two main types of autophagy macroautophagy and microautophagy. 
Each type has specific purpose and a different mechanism to sequester its correlating 
cargo, but both have nonselective and selective properties46. In general, non-selective 
autophagy involves the turnover of bulk cytoplasm under starvation conditions, while 
selective autophagy involves sequestering specific targets damaged or superfluous 
organelles (mitochondria and peroxisomes) and invasive microbes43,47,48. Unlike 
macroatuophagy, microautophagy cargo sequestration involves direct invagination of the 
vacuolar membrane29,49.  Macroautophagy is the most common autophagy pathway, 
which is conserved throughout eukaryotes. Macroautophagy involves sequestering 
cytosolic material into a double-membrane vesicle, autophagosomes43.  After the 
formation of the autophagosomes, it is important to distinguish differences between 
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fungi/plant and higher eukaryotes for the rest of the autophagy pathway50. The main 
difference lies with the fusion of autophaosome. In yeast, the autophagosome fuses with 
the vacuole, rather than lysosome in higher eukaryotes50. An important autophagy feature 
exclusive to yeast is the fusion of the double-membrane autophagosome with yeast 
vacuole generating single membrane autophagic bodies (autolyosomes) within the 
vacuole50. Characteristic to yeast, the autophagic bodies can accumulate in the vacuole 
lumen when the cells have a genetic mutation that causes dysfunction in autophagy 
genes50. It is important to note that only autophagic bodies occur in yeast due to the 
massive size of a yeast vacuole compared to the higher eukaryote lysosomes.  In higher 
eukaryotes, the autophagosomes move along microtubules, where they will fuse with the 
lysosome to form autolysosomes51. The general macroautophagy proceeds as the 
following steps phagophore assembly site (PAS), isolation membrane, phagophore, 
autophagosome, fusion with vacuole/lysosome, protein degradation, and protein recycle 
(Figure 2). The PAS is a compartment or peri-vacuolar location where the nucleation of 
the phagophore initiates and exists only in a transient state43,52–54. The phagophore is a 
double-membrane structure that makes up the active component of macroautophagy and 
is involved in the initial cargo sequestration55. Unlike the phagophore, the autophagsome 
is the product of the completed phagophore extension56,57.   
Over 30 genes were found in yeast to be involved in the autophagy pathway43. 
There are 18 genes that make up the core autophagy proteins43. These 18 genes are genes 
shared amongst the different types of autophagy systems43. The core proteins can be 
furthered categorized into 4 different functional subgroups Atg1, Atg9 complex, PtdIns 




Atg1 is the initial autophagy complex responsible for induction of 
autophagosomal function43. The yeast Atg1 complex is composed of Atg1, Atg11, Atg13, 
Atg17, Atg29, and Atg3143. This Atg1 complex is the primary complex that regulates the 
magnitude of autophagy40,41,58–60. Atg1 is a Ser/Thr protein kinase, which functions both 
in autophosphorylation and phosphorylation of others; although, it’s specific substrates 
are unknown61.  Atg13 is a regulatory subunit that is required for optimal Atg1 kinase 
activity40,43. Lastly, Atg31, Atg17, and Atg29 exist as a heterocomplex. Specifically, 
Atg31 bridges the contact between Atg17 and Atg2961.  Atg17-Atg31-Atg29 complex 
functions as a scaffold43.  
Atg1 is highly regulated in accordance to nutrient signaling by TOR or PKA 
phosphorylation62. In addition, its characteristic as an autophosphorylator acts as a self-
regulator of its own kinase activity62,63. Similar to Atg1, Atg13 is regulated by TOR 
and/or PKA. TORC1 hyperphosphorylates Atg13 under nutrient-rich conditions and is 
desphosphorylated under starvation induced autophagy64. The hyperphosphorylated 
Atg13 by TORC1 inhibits its ability to bind to Atg1, Atg17, Atg31, and Atg29 (Figure 
3)41,42. Therefore, desphosphorylation of Atg13 of the Atg13-Atg1 complex permits the 
formation of its complex with Atg17-Atg29-Atg3143.  
Atg17-Atg31-Atg29 complex functions as a scaffold for induction of autophagy 
by converting the PAS to an autophagy-specific PAS65,66. It was proposed that Atg17 
may play a role in recruiting Atg proteins to PAS61. PAS is constitutively expressed 
under stable conditions marked with Atg11, but autophagy transition causes the function 
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of Atg11 to be replaced by the Atg17-Atg31-Atg29 complex65,66. Another role Atg1 
complex is involved in is the retrieval of Atg9 from PAS67.  
 
Atg9  
Atg9, transmembrane protein, complex exist between the PAS and peripheral 
sites43. This complex is considered the cycling system for membrane delivery to PAS 
from peripheral sites and is composed of Atg2, Atg9, and Atg1843. The Atg9 complex 
major role involves membrane delivery PAS for expansion into a phagophore after the 
Atg1 complex assembly to PAS43. Atg9 movement from peripheral sites to PAS, 
anterograde transport, depends on Atg11, Atg23, and Atg2767–70. Returning to the PAS 
from peripheral sites, retrograde movement, requires Atg1-Atg13, Atg2, and Atg1843.   
 
PtdIns 3-kinase Complex 
 Phosphoinositide 3-kinase (PtdIns3K) complex is important for staging the 
vesicle for nucleation43.  Yeast PtdIns3K is composed of Vps15 (a putative regulatory 
protein kinase that is required for vps34 membrane association), Vps30/Atg6, Vps34 (the 
PtdIns3K), Atg14 and Atg3871–73. PtdIns3K complex is localized on the PAS71–73. It is 
presumed, a key role of this complex, generating PtdIns-3P, is to recruit PitdIns3P-





Ubiquitin-like Complexes  
There are two ubiquitin-like complexes within yeast, Atg8 (Atg3, Atg4, Atg7, 
Atg8) and Atg12 (Atg5, Atg7, Atg10, Atg12, Atg16)43. This ubiquitinated-like 
conjugated system functions in phagophore expansion43. Atg8 is initially synthesized 
with C-terminal Arginine, but is then cleaved by Atg4 (cysteine protease), exposing the 
C-terminal Glycine61. Agt7 then activates the processed Atg8, promoting the transfer to 
Atg361.  Atg3 is responsible for creating the covalent bond between 
phosphatidylethanolamine, PE, and Atg8, creating the lipidated form of Atg8 – Atg8PE 
localizing to the PAS61 (Figure 4). Atg8 also functions in cargo binding during selective 
autophagy74.  However, it can also be recycled by Atg4 cleaving the amide bond between 
the Atg8 and PE, allowing for Atg8 to re-enter the conjugation process61. Atg8 has the 
greatest change in synthesis during autophagy and the amount of protein produced is 
correlated to the size of the autophagosome75–77. Therefore, Atg8 is a good marker and 
tracker for autophagic activity in yeast. It is also a good marker for mammalian 





ESCRT complex  
 
Introduction 
The study of the endosomal sorting complex required for transport (ESCRT) is an 
active research field. ESCRT research is constantly uncovering new functions and 
mechanistic details. Its first molecular insight was discovered in Saccharomyces 
cerevisiae78. ESCRT protein form transient protein complexes that are responsible for 
multivesicular body (MVB) biogenesis from endosomes through the generation of 
intralumenal vesicles (ILV)78. The primary role of the ESCRT machinery is endosomal 
protein sorting through ILV of the MVB78. Sorting proteins in ILVs of the MVB is 
completed by 4 different subcomplexes (ESCRT-0, I, II, III), ATPase VPS4, and multiple 
accessory protein factors that assist during disassembly and recycling of ESCRTs79. 
Although the primary role of ESCRT machinery is endosomal trafficking, their functions 
of the ESCRT machinery extends well beyond 79. In fact, their functions are dynamic and 
heterogenic between different species. Their extended function range from cellular 




ESCRTs are dynamic protein complexes involved in a large array of cellular 
functions. Sorting proteins in ILV has multiple purposes. ILVs of the ESCRT pathway 
are known to facilitate the delivery of proteins that are destined to degraded by the 
lysosome78. Most importantly, ESCRT endosomal trafficking is used as a regulatory 
mechanism for membrane and cytosolic proteins78. Thus, enabling its involvement in the 
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following cellular processes quality like control of misfolded proteins, cellular signaling 
regulation, apoptosis, TOR, biogenesis and release of exosomes, cytokinesis, and viral 
budding (Figure 5) 78. Recent research has uncovered the importance of ESCRT in the 
regulation of cellular signaling.  
 
Cellular Signaling 
In general, from Caenorhabditis elegans, Drosophila melanogaster, mouse cells and 
human cells, ESCRT mutant cells fail to sort and degrade components of conserved 
signaling proteins like receptor tyrosine kinases, g-protein couple receptors (GPCR), 
transforming growth Beta receptors, Hedgehog receptors, Wnt, t-cell receptor, Toll 
receptors, and Integrins80. Therefore ESCRTs are signaling modulators, both positively 
and negatively, which occurs through multiple pathways. Signaling regulation is possible 
through signaling degradation, signaling sequestration, and receptor recycling78–80. As a 
result, failing to sort or degrade these signaling components results in dysregulated 
signaling in ESCRT mutant cells, which provide strong evidence of the requirement of 
ESCRT machinery for cellular signaling throughout species80.   
ESCRTs are required to efficiently modulate receptor tyrosine kinase signaling. 
ESCRTs mutants results in prominent alterations of cellular signaling by leading to 
receptor accumulation, ending in upregulation of cellular signaling80. Therefore, 
expression of ESCRTs can be negative regulators of receptor tyrosine kinase signaling by 
sequestering the signaling receptor and directing the receptor for lysosomal degradation, 
thereby restricting the receptor signaling pool size through MVB-lysosomal 
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degradation79. A common receptor tyrosine kinase that is dysregulated in ESCRT mutant 
cells is the epidermal growth factor receptor (EGFR). ESCRT-0 (hrs) D. meleanogaster 
mutant embryos, express developmental aberrations during active EGFR signaling by 
failing to undergo proper morphogenesis within the tracheal cells80.  More importantly, it 
was observed down-regulation of ESCRT-1, tsg101, led to the reduction of signaling 
degradation and resulted in a sustained EGFR signaling in response to EGF within 
cultured mammalian cells79. In vivo experiments of D. melangoster cells with depleted 
ESCRTs led to increased EGFR activity and enhanced MAP kinases activity79. This 
example is a result of failed signaling degradation by ESCRTs. Failing to attenuate the 
signal, the active signal accumulates and the active signaling pool is maintained, 
concluding to a sustained signaling.  Therefore, ESCRT-depleted cells result in active 
accumulation of EGFR signaling causing sustained signaling for cellular proliferation. 
Extended studies in ESCRT mutant in D. melanogaster epithelia revealed the loss of 
ESCRT function results in a strong non-autonomous cellular proliferation79. Meaning 
ESCRT mutant cells exhibit the mutant phenotype upon surrounding cells. The 
phenotype of non-autonomous cellular proliferation phenotype provides evidence of a 
close interactive link with cellular survival function of ESCRT mutant cells, which I will 
explain shortly. In conclusion, receptor tyrosine kinase, EGFR, signaling will be 
prolonged in cells with dysfunctional ESCRTs 81. As a result, cells will have sustained 
proliferation.  
ESCRT-mediated signaling attenuation also occurs in the innate immune system of 
toll-like-receptor (TLR) signaling.  It has been shown that trafficking of intracellular 
TLRs is important for their signaling82, especially critical when the endpoint is to activate 
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NFκB transcription factor79.  Signaling regulation of TLR occurs in similar fashion of 
ESCRT modulation of receptor tyrosine kinase, signaling degradation.  TLR4 recognizes 
certain pathogen-associated molecular pattern (PAMPS), such as lipopolysaccharide 
(LPS) of gram negative bacteria. TLR4 is ubiquitinated upon  binding to LPS, which 
enables recognition by HRS of ESCRT-0 and promotes degredation83. ESCRT and its 
TLR4 signaling regulation is furthered strengthen by the inhibition of endocytosis and 
endosomal sorting of TLR4 resulting in an increase LPS-induced signaling79.  
Aside from signaling attenuation, ESCRTs have a positive influence on cellular 
signaling by promoting sequestration rather than degradation in the Wnt pathway. Wnt 
canonical signaling pathwayknown for its developmental embryonic regulation and its 
importance in stem cell maintenance79. Wnt signaling stabilizes β-catenin80. In 
unstimulated cells, β-catenin is phosphorylated by the cytosolic glycogen synthase 
kinsase 3 (GSK3) promoting its polyubiquination and proteosomal degradation78,80. In 
Wnt stimulated cells, active wnt signaling binds to its receptor, Frizzled, and co-receptor, 
LRP6, to inhibit the phosphorylation by GSK3 on β-catenin79. This allows β-catenin to 
accumulate in the nucleus and activate Wnt targeted genes.  Until recent studies, Wnt-
mediated receptor activation mechanism has been fleeting79,80. Studies are discovering in 
response to Wnt, GSK3 is sequestered within the ILV of MVB in an ESCRT dependent 
manner80,84. Sequestering GSK3 by MVB enables the stabilization of β-catenin 
permitting its transcription of Wnt targeted genes. However, the crosstalk between Wnt 
signaling and ESCRT sequestration of GSK3 mechanism remains elusive79,80. In-vitro 
experiments of Xenopus embryos, have shown GSK3 sequestration requires HRS and 
Vps4 ESCRT proteins84.  
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Cell survival  
Not only are ESCRTs involved in EGFR signaling but ESCRTs are also involved in 
cell survival. As I mentioned before, ESCRT mutant cells in D. melanogaster promote a 
non-autonomous cellular proliferation signaling; meaning that the surrounding cells of 
the ESCRT mutated cells will proliferate. Mutations in the ESCRT subunits of model 
organisms result in a prominent phenotype, cell-autonomous death through apoptosis79. 
In vivo studies suggest the lack of survival in ESCRT deficient cells is a reflection of cell 
death program activation upon the dysregulated response of cellular signaling78. 
Apoptosis induced by ESCRT deficiency was observed within the endoderm of the 
ventral region of HRS-/- mouse embryos85. Additionally, apoptosis induced by ESCRT 
deficiency was demonstrated in cells derived from mice with a conditional knockout of 
Tsg10186. Cells that fail to correct problems or are arrested too long at a cell cycle 
checkpoint will activate apoptosis and die79. Yet again, this prominent phenotype was 
confirmed by D. melanogaster clones of epithelial cells with ESCRT mutations within 
subunits I, II, or III, which failed to grow in response to active apoptotic pathway 
induction by caspase activation87–92.  
The mechanism of apoptosis induction in ESCRT-deficient cells remains elusive. 
There are at least  two potential mechanisms to explain the phenotype, dysregulation of 
the inhibitor survival signal or direct induction of proapoptotic signaling79. The fisrt case 
seems plausible by  the down-regulation of DiapI/IAPI, a critical caspase inhibitor, 
occurs in ESCRT mutant epithelial cells of D. melanogaster91. The direct proapoptotic 
induction mechanism can be is observed by the  upregulation of proapoptotic regulators 
such as, Hipp/Mst1/JNK/Hid, in ESCRT mutant D. melanogaster cells79.  
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Biogenesis and Release of Exosomes 
Apart from the role of ESCRTs in cellular signaling, ESCRTs also have an alternative 
destination aside from lysosome degradation, the biogenesis and release of exosomes. 
Rather than having ILV of the MVB destined to the lysosome, MVB can fuse with the 
plasma membrane resulting of the release of ILV into the extracellular space78. Now ILV 
in extracellular space are now called exosomes78. Researchers are realizing that all cells 
have the potential to use the release of MVB-derived exosomes, as a form of intercellular 
signaling mediator93. Exosomes provide a protective pathway for transferring 
hydrophobic signals and cytoplasmic material between cells78. Although, what induces 
the switch between MVB destinations remains elusive. An example of the MVB 
destination switch is seen within antigen-presentation among dendritic cells and B-cells94. 
In immature cells, MHC II is targeted to the lysosome for degredation, but within 
activated cells, MHC II is secreted on exosomes94. Additionally, only degradative sorting 
of MHC II requires ubquitination, giving insight into mechanistic differences among 
MVB destinations78. Another potential molecular difference of MVB destination to 
exosomes, is the requirement of RAB GTPases, RAB27A and RAB27B, for targeting and 
docking of MVB to the plasma membrane78. Another example supporting a role for 
MVBs in biogenesis and release of exosome resides in brain-derived oligodendrocytes. In 
brain-derived oligodendrocytes, myelin membrane protein is known to be stored in MVB 
and, only upon neuronal contact leads to the induction of MVB exosome secretion95. 
MVB biogenesis and release of exosomes exemplifies ESCRT plasticity.   
 
Viral Budding   
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 ESCRTs also have a role HIV-1 budding. Viruses commandeer ESCRT machinery to 
assist their release from the host cell96,97.  HIV-1 Gag proteins contain the same motif as 
HRS (ESCRT-0) in order to recruit Tsg101 - enabling the virus to bud away from the 
cell98–101.  Binding of Tsg101 to gag proteins initiates the engagement of additional 
ESCRT components to proceed through the canonical ESCRT pathway102. The 2nd late 
domain of viral structural proteins interacts with Alix, which is part of the ESCRT-III 
accessory proteins103,104.  Alix binding to 2nd late domain could also happen in 
conjunction with binding of Tsg101 to gag proteins78. It is important to note, not all 
ESCRT components are utilized in HIV-1 viral budding process. In addition to Tsg101 
and/or Alix, only a subset of ESCRT III proteins, CHMP4A/B and Vps4A/B, are 
recruited during the final stages of budding process in mammalian cells105.  
Not only are ESCRTs important for virus budding, but ESCRTs are critical for the 
final abscission of virion particles106. The action of virus particles pinching off host 
plasma membrane requires ESCRT assistance. In general, ESCRT machinery is used to 
bend membranes until the neck can be scissioned106.  Once HIV-1 gag proteins complete 
recruiting Tsg101 and Alix, ESCRT-III and Vps4 proteins are then recruited to budding 
sites within a few minutes, moments before the release of viral particles106.  The ESCRT 
machinery is also involved in the abscission process of cytokinesis, but unlike 
cytokinesis, HIV-1 viral budding uses slightly different ESCRT machinery.  For HIV 
budding, only two ESCRT-III subunits CHMP4 and CHMP2 are required to  construct a 
50 – 100 nm diameter ring-like structure in the membrane stalk, which connects the viral 
particle with host cell surface of CHMP4-or CHMP2-depeleted cells105,106.  CHMP4/2 
depletion prevents ESCRT-III filament to fully assemble, blocking viral budding for host 
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cell surface106. For successful membrane scission to release viral particles requires the 
AAA-ATPase Vps4.  Vps4 is responsible for efficiently removing ESCRT-III subunits 
from the membrane stalk, allowing for the release of the viral particle106. However 
discrepancies remain in how Vps4 is involved in releasing ESCRT-III from membrane 
stalk. Some researchers proposed that the Vps4 could simply strip ESCRT-III from the 
membrane. Others have hypothesized that Vps4 progressively remodels ESCRT-III to a 




Membrane abscission facilitated by ESCRT machinery also occurs in cytokinesis 
during the separation of daughter cells from one another. Although the ESCRTs are 
required for cytokinesis, not all subunits of the ESCRT canonical pathway are required. 
In fact, only ESCRT-I and ESCRT-III are essential, while ESCRT-0 and ESCRT-II are 
not involved80. This is evident by observing ESCRT-I and ESCRT-III-depleted cells 
arrest during the final stages of cytokinesis80. Proper completion of membrane scission 
during cytokinesis and ESCRT disassembly from target membrane requires AAA-
ATPase Vps480,106. It has been established that ESCRT-III and Vps4 are essential ESCRT 
components for proper separation of the two daughter cells during cytokinesis106.  
During the separation of the two daughter cells is the formation of a thin membrane 
stalk, which keeps both daughter cells connected107. The middle of the membrane stalk is 
defined as the midbody. At the midbody of the membrane stalk exists the binding of an 
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important protein for ESCRT recruitment, CEP55, a centrosomal protein80,106. CEP55 
recruits ESCRT-I subtunit Tsg101 and Alix to the midbody80,106. At the midbody, Tsg101 
forms large rings, roughly 1µm, on each side of the midbody106. In succession, the 
recruitment of ESCRT-III subunits (CHMP6/4/3/2/1) results in the formation of a long, 
ring-like filament along the Tsg101 ring, eventually creating a constriction site at 
opposing ends of membrane stalk is critical for membrane scission80,106. A dynamic 
characteristic of ESCRT-III filament is profound in its ability to first localize at the 
midbody Tsg101 ring, but later move towards the constriction zone106. The movement of 
ESCRT-III filament towards the constriction zone at the late stage of cytokinesis creates 
a 17nm helical filament, which can be observed on electron tomography of high-
pressured frozen cells108. The top of the helical filament the ESCRT-III subunit CHMP1b 
recruits AAA-ATPase spastin, which is required to cleave microtubule bundles, severing 
the membrane abscission at the constriction zone106,108,109. The combination of ESCRT-
III filaments and spastin and Vps4 are required for proper cytokinesis completion108.  
However, there are multiple models to explain the dynamic movement of ESCRT-III 
filament towards the constriction zone108,110,111. The first model describes the 
polymerized ESCRT-III subunits to project along the initial assembled ESCRT-III 
filaments at the midbody to the constriction106. As it moves towards the polar end of the 
membrane stalk, the dynamic ESCRT-III filaments somehow decrease their diameter, 
creating a gradual constriction of the membrane leading to the formation of the 
constriction zone106. An alternative model is Vps4 mediated. Vps4 remodels or breaks the 
initial ESCRT-III filament ring to generate a smaller ESCRT-III scission complex to 
migrate to the constriction zone106. ESCRTs involvement in membrane scission during 
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cytokinesis expresses the importance of ESCRTs in forming structured cellular 




ESCRTs may also have a role in autophagy. However, its role in autophagy varies 
between species. There are no known common ESCRT-autophagy mechanisms shared 
between all organisms. In fact, mammals and Drosophila share many common aspects, 
unlike C. elegans. C. elegans is the exception to the rule. They have their own particular 
ESCRT-mediated autophagy pathway.  This displays another level of dynamics ESCRTs 
hold through the animal kingdom.  
Autophagy is a widely used cell survival pathway during times of hardship and exists 
at a basal level. There are many forms of autophagy, but the main autophagy pathways 
are known as macroautophagy.  To summarize, macroautophagy is responsible for 
sequestering (damaged) cytosolic components (including organelles) into double 
membrane vesicles known as autophagosomes. The autophagosome develops from the 
elongation of the phagophore, which requires the recruitment of Atg8/LC3 
(yeast/mammals)112. The closure of the phagophore creates the autophagosome, in where 
a phosphatidylethanolamine (PE) conjugated (lipidated) form of Atg8/LC3II is present112. 
The lipidated form is the universal marker of autophagosomes112. There upon the 
autophagosome will merge with the vacuole/lysosome committing the cytosolic 
components for degradation.  First insights of endosomes involvement with autophagy 
originally came from observations of ESCRT III mutants and its associations with 
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neurodegenerative disease, in addition to the discovery of protein aggregates expressing 
both ubiquitin moiety and p62 autophagic adaptor proteins113–115. Thus provides a 
foundation for the possibility of an alternative autophagy route where autophagosomes 
fuse with endosomes to generate intermediate vesicles called amphisomes in 
mammals80,112. Evidence that ESCRTs influence  autophagy is provided by effects of 
ESCRT deficiencies in C. elegans, Drospophila, and mammals leading to an 
accumulation of atuophagosomes due to the inhibition of autophagic maturation80. 
Relevant to my studies, ESCRT proteins, which were discovered in yeast, have not found 
to be associated with starvation-induced macro-autophagy in yeast80.  
It is still unclear  how exactly ESCRTs regulate macroautophagy80. Research revealed 
a common theme where ESCRT-0, ESCRT-I, and ESCRT-III are  the most influential on 
the autophagy process112. Combined in-vitro experiments of siRNA knockdown of 
Vps23/Tsg101 (ESCRT-1) or Vps24/chmp3 (ESCRT-III) cultured cells with co-
localization, western blots, and electron microscopy images led to the observation of 
enlarged vesicular structures and their characterization116. Characterization of these 
enlarged vesicles are the appearance of large ubiquitin positive structures associated with 
endosomal markers, but are also associated with autophagic proteins, p62, and 
autophagosome marker, Alfy (autophagy-linked FYVE protein), and GFP-Atg8p/LC3116.  
EM images of VPS23/tsg101 and VPS24 depleted cells show presences of 
autophagosomes, amphisomes, but not autolysosomes112. Further analysis of autophagy 
activity results in expression of both the lipidated Atg8p/LC3II form and Atg8p/LC3 
form - supporting the idea that ESCRT mutants inhibit the fusion of autophagosome with 
the lysosome112. In conclusions, ESCRT subunit depletion inhibit autophagic maturation, 
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which results in the accumulation of ubiquitin-positive aggregates in autophagosomes 
and amiphosomes112. Prevention of autophagosome maturation into autophaglyosomes is 
also impaired in Vps27/Hrs depleted cells112.  Similarly, mice with mutated 
VPS2/chmp2B or depletion of VPS32/mSnf7-2 subunits of ESCRT-III results in 
accumulation of both lipidated and non-lipidated forms of Atg8/LC3 auophagosomes112. 
One can conclude ESCRT-III dysfunction might interfere with fusion between 
autophagosomes and MVB112.  The inhibition of autophagosome maturation, inhibiting 
lysosome fusion, leading to accumulation of autophagosomes with or without the 
additional accumulation of amphisomes provides one the main hypotheses of how 
autophagy is defective within ESCRT mutants112.  
The role of ESCRTs in autophagy in C. elegans provides further molecular insight of 
the relationship between ESCRTs and autophagy. Unlike mammals and Drosophila, C. 
elegan ESCRT mutants revealed an increase in the number of autophagosomes, but is not 
due to fusion blockage, rather it is due to the induction of  autophagic flux indicated by 
western blotting116. Induction of autophagic flux is an alternative hypothesis to explain 
the link between ESCRT deficient cells and their autophagy phenotype. 
Even though it is unclear how ESCRTs regulate macro-autophagy, ESCRTs 
involvement in microautphagy, endosomal microautophagy, is easier to comprehend. 
Endosome microautophagy selective delivers certain cytosolic proteins to vesicles of late 
endosome during MVB biogenesis117. Endosomal microautophagy does not require 
LAMP2A, lysosomal marker, but rather requires ESCRT-I (Tsg101), ESCRT-II 
components, and VPS4117. My thesis experiment will further explore the possibility of 
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yeast ESCRTs interaction with autophagy based on the unique phenotype arise from our 
labs yeast screening.  
 
 
ESCRT Pathway  
 
Introduction 
The first insight of a vesicles containing ILVs was in 1950’s by Keith Porter and 
George Palade.   Not until almost 20 years later was the first molecule insight of MVB 
were uncovered in Saccharomyces cerevisiae. In 1980’s and 1990’s the laboratories of 
Emr and Stevens first identified “ESCRT” mutants to display a vacuole protein sorting 
(VPS) defect, classifying them as class E VPS proteins118–122. Extensive biochemical 
studies revealed these class E proteins were distinct from normal class E protein in that 
these proteins form distinct complexes that directly mediate cargo trafficking and were 
later named as endosomal sorting complex required for transport (ESCRT). In 1997 
Babst and colleagues123 first identified the AAA ATPase Vps4 as part of the ESCRT 
pathway. Vps4 is an integral component of disassembly complex (ESCRT-IV) that is 
responsible for dissociating ESCRT proteins from endosomal membranes123. Four years 
later, in 2001, yeasts ESCRT-I was characterized and was shown to engage in 
ubiquitinated cargo on endosomes and then sort cargo through MVB124. Then ESCRT II 
and ESCRT-III complexes were discovered and defined as important players of 
ubquitinated cargo delivery of yeast vacuoles125. ESCRT-0 was discovered later than the 
other ESCRT complexes. ESCRT-0 is critical for MVB biogenesis and functions in 
recruiting ubiquintinated cargo to endosomal membrane through its of FYVE domain78. 
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Combining all findings suggests the ESCRT complexes are only present transiently on 
the membrane due to disassembly of ESCRT-III proteins by Vps4126. Biochemical studies 
propose the assembly of ESCRT machinery on endosomal membranes occur in a 
hierarchal fashion127,128. Starting with initial recruitment of ESCRT-0 and sequentially 
ending recruitment with ESCRT-III127,128. Multiple studies establish ESCRT proteins are 
responsible for constructing inward invaginations of the endosomes forming ILVs, which 
become the defining characteristic of MVB biogenesis. ESCRTs are extensively studied 
to understand the mechanism ESCRTs use to invaginate the membrane. Now more than 
30 genes are involved in the ESCRT pathway (Table 1)128. Two categories can be used to 
categorize ESCRTS. Early-acting ESCRT complexes comprised of ESCRT-0, ESCRT-I, 
and ESCRT-II128. Lastly, late-acting modules that specifically function on membranes 




ESCRT-0, the primary sub-complex to initiate the binding of ESCRTs to 
endosomes and recruitment of ubiquitinated cargo to be sorted through MVB. ESCRT-0 
is a heterodimeric protein complex of Hrs and STAM1/2 (Vps27 and Hse1 in (Table 
1)78,129. The two ESCRT-0 subunits interact at 1:1 ratio via anti-parallel coiled-coil 
structured formed by 2 domain-swapped GAT domains (GGAs and Tom)129–131.  The 
heterocomplex dimer undergoes oligomerization on membranes generating a 2:2 
heterotetramer132. 2:2 heterotetramer brings the two subunits together to create eight low 
27 
 
affinity ubiquitin binding motifs giving the avidity required for ubiquitin- dependent in-
vivo cargo sorting128.  Both subunits contain ubiquitin binding domains128.    
 Hrs is the primary subunit involved in recruiting ubiquitinated cargo and 
localized to the endosome membrane. Hrs subunit contains multiple motifs, a VHS 
domain, FYVE domain, DUIM, PxxP, CC, and CB78,128,129. Each domain has plays a 
specific role in Hrs subunit function.  The ubiquitin binding domain, DUIM, has a higher 
affinity for ubiquitin than its partner subunit, STAM1/2, because its potential to engage 
two ubiquitin molecules simultaneously132,133. In addition to DUIM domain, Hrs VHS 
domain also has the potential to bind to ubquitinated molecules, but at a weaker 
affinity128.  The difference between the two ESCRT subunits lies within the expression of 
the FYVE (Fab-1, YGL023, Vps27, and EEA1) domain of Hrs78,129. FYVE domain is 
critical for localizing ESCRT-0 to endosomal membrane and initiating the ESCRT 
recruitment to the endosomes78. FYVE domain of Hrs binds to phosphatidylinositol 3-
phosphate (PI(3)P), providing endosomal specificity and membrane recruitment129,134. 
The presence of the FYVE domain in Hrs categorizes ESCRT-0 recruitment to early 
endosomes135. Another primary responsibility of ECRT-0, recruitment of ESCRT-I, is 
carried out by the PxxP motif in the Hrs subunit78,128.  The coiled coil domain (CC) is 
involved in the interface connection between the two subunits, Hrs and STAM128.  
Finally, the Hrs subunit also contains a clathrin-binding motif, CB78,128.  The clathrin-
binding motif enables ESCRT to bind with flat clathrin lattices that assemble on early 
endosomes78,134,136.  
STAM’s motif are similar in that it shares with Hrs are the VHS, CC, and DUIM 
domains.  VHS and DUIM domain associate with ubiquitin molecules, but at a weaker 
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affinity137. However, it does not have a PxxP or FYVE domain.  Instead STAM contains 
SH3 domain that binds to deubiquitinases (DUBs) such as AMSH, USP8 and 
UBP478,128,138,139.   ESCRT-0 is responsible for recruiting ubiquitinated cargo to the 
endosomal membrane through its various motifs, but it is also important in recruiting 





In subsequent fashion ESCRT-I is recruited in the ESCRT canonical pathway. 
ESCRT-I was the first complex to be identified in yeast and is a heterotetrameric 
complex composed of Vps23, VPS28, and VPS37, and Mvb12 (Table 1)124,128,140,141. 
Mammalian ESCRT-1 components are slightly different from that of yeast. They consist 
of Tsg101, Vps28, Vps37, hMVB12 isoforms, and recently discovered UBAP-1 isoforms 
(Mvb12-like protein)142–148.  ESCRT-I subunits are in 1:1:1:1 stoichiometry ratio that 
generates an elongated 20nm long heterotetramer complex142,143,146,147.  Crystal yeast 
structure revealed ESCRT-I structure to be composed of three subunits intertwined within 
a long coiled-coil stalk with a globular head group, which can engage in binding with 
ESCRT-0 and ESCRT-II146,149. However, the structure of metazoan ESCRT-I remains 
elusive.  
Hrs carboxyl-terminus PxxP motif associates with Tsg101 via an ubiquitin E2 
variant (UEV) domain of ESCRT-II enabling the recruitment of ESCRT-I to the 
endosomes150–153. Utilizing a different region aside from Tsg101 – Hrs interacting motif 
of the UEV domain is the region of the motif responsible for binding ubiquitin, but only 
at a low affinity in mammals98,124,151,154,155. Suggests ESCRTs role in ubiquitin-dependent 
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cargo sorting128. Yeast ESCRT-1 contains two ubiquitin binding domains, one in N-
terminal of UEV domain of Vps23 and another one in C-terminal of Mvb12; together 
these contribute to ESCRT-I ability to bind and sort ubiquitin cargo into MVBs148.  As 
mentioned before, yeast Mvb12 has been show to bind to ubiquitin and participate in 
cargo sorting, but, mammalian UBAP1 (Mvb12-like protein) expresses an ubiquitin 
binding characteristic142,156,157.  The discovery of UBAP1 confirms the ability of ESCRT-
I participation in ubiquitin-dependent cargo sorting.  
UBAP1 binds to the central stalk of ESCRT-I through binding to N-terminal 
UBAP1-MVB12-associated (UMA) domain158. At the polar end of UBAP1, its C-
terminal region contains three concatermerized ubiquitin-associated (UBA) domains to 
allow UBAP1 to bind to ubiquitin molecules148. UBAP1 depletion studies conclude the 
importance of UBAP1 to ESCRT-I function in MVB sorting because sorting requires the 
high affinity of ubiquitin binding activity that UBAP1 can provide, while other ESCRT-I 
components do not148. The discovery of UBAP1 has the potential to explain the structure 
of mammalian ESCRT-I. Lastly, Vps28 subunit of ESCRT-I contains a C-terminal 
domain (CTD), which functions to recruit ESCRT-I to ESCRT-II128,129. Together 
ESCRT-I and ESCRT-II are necessary requirements for inward budding of vesicles at the 
endosomal membrane159.  
ESCRT-II 
ESCRT-II is next to be recruited to the endosome by ESCRT-1.  ESCRT-II 
subunits forms a stable heterotetramer composed of Vps22 (Snf8, yeast), Vps36, and 2 
copies of Vps25160,161. A defining characteristic of ESCRT-II is the structure formed by 
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its subunits. The heterotetramer forms a Y-shaped; Vps22 and Vps36 forms the base of 
the Y shaped and the two Vps25 form the arms of the Y (Figure 6)128,162,163.  
Vps36 subunit is an important ESCRT-II subunit, not only, to bind ESCRT-I, but 
also important strengthening the localization of ESCRTs to the endosomal membrane. 
The Vps36 contains Gram-like ubiquitin-binding in Eap45 (GLUE) domain, which is 
responsible for  high affinity binding to PI(3)P164–166. A common aspect between both 
yeast and mammalian GLUE domains is that they share the ability to  bind to ubiquitin 
and phosphoinositide 165,167,168. The  domain structure of yeast Vps36 and mammalian 
Vps36 differs by the presence of two Np14type zinc fingers (NZF) inserted into the yeast 
Vps36 GLUE domain165,167,168. Each NZF insert of the yeast Vps36 GLUE domain has a 
distinct function. One NZF insert is responsible for binding Vps36 to ESCRT-1 subunit 
Vps28 through the C-terminal domain (CTD)166,168. The second NZF insert is responsible 
for binding to ubiquitin,  though with low binding affinity133,165,167. ESCRT-II would be 
categorized in the early-acing ESCRT machinery components133,165,167.  
Vps22 of ESCRT-II contains a conserved basic helical domain (HD)128. The 
helical domain associates with acidic phospholipids, and is required for ESCRT-II 
endosomal targeting161. Lastly, ESCRT-III Vps20 is recruited to ESCRT-II by binding to 
Vps25 two subunits through their winged-helix domain (WH2)128. The interaction of 
Vps20 and Vps25 WH2 domain occurs at a high affinity128.  
ESCRT-III 
 ESCRT-III has several interesting features. Firstly, it does not form a stable 
cytoplasmic complex. It creates polymerized filaments and promotes membrane 
curvature, but the mechanisms of ECRT-III in invagination of the membrane still remains 
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a mystery.  The ESCRT-III complex is made out of four core components Vps20, Snf7, 
Vps24 and Vps2 169. Mammalian homologs of the four yeast core components are  
denoted as charged multivescular binding proteins (CHPMs), CHMP6, CHMP4, 
CHMP3, and CHMP2129.  
 ESCRT-III monomers are localized in the cytoplasm where they are 
autoinhibited, which promotes a “closed state” 129. The recruitment of ESCRT-III subunit 
Vps20 to endosomes by ESCRT-II induces Vps20 from closed state to active state129. 
When Vps25 forms the arms of the Y-shaped structure, binds the open state of Vps20 in 
ESCRT-III subunit, which then initiates the recruitment of the rest of ESCRT-III subunits 
to the endosomes. Vps20 then recruits multiple Snf7 subunits, which homo-
oligomerizes129. Snf7 polymer formation is important for ESCRT-III to deform the 
membrane and create membrane invaginations. The Snf7 polymer is then capped by 
Vps24-Vps2129. However, there are multiple theories of the mechanism used by ESCRT-
III to create invaginations in the membrane, such as theSnf7 classical oligomerization and 
dome model129. Snf7 also recruits adaptor proteins Bro1/Alix, responsible for stabilizing 
Snf7 filaments, and Doa4, deubiquitinating enzyme necessary for cargo 
deubiquitination170,171. After the recruitment of all ESCRT-III subunits begins the 
recruitment of Vps4-Vta1 complex (ESCRT-IV). 
 
Vps4 Complex (ESCRT-IV) 
 Vps4 is required for ESCRT-III to disassemble properly129. The Vps4 complex is 
comprised of Vps4, Vta1, and Vps60129. Vta1 and Vps60 are considered to be 
“accessory” subunits of ESCRT-IV and they govern the interaction of Vps4 with 
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ESCRT-IV. ESCRT-III disassembly requires energy to dissociate from the membrane, 
which is provided by the AAA ATPase activity of Vps4126. Vps4 a multimeric enzyme 
binds to multiple ESCRT-III subunits through its Microtubule Interacting and Trafficking 
(MIT) domain123,172. It is important to note that Vps4 can exist in two states. In an ADP-
bound state it exists as a monomer or a dimer, but when fully assembled it multimerizes 
into a stable dodecamer of two hexameric rings and a supercomplex with 
Vta1123,129,173,174. The multerimization of Vps4 initiates ATP hydrolysis, which is required 
for removal of ESCRT-III subunits from the membrane129. There are multiple theories of 
how Vps4 complex is involved in ESCRT-III invagination process (membrane scission).  
 
ESCRT-III mechanism in creating membrane invaginations 
Like classical vesicle budding, ESCRT-III subunits bind to lipid membranes 
electrostatically and some subunits can oligomerize175–177. When Vps25 recruits Vps20 
and Vps20 recruits Snf7, Vps20 then nucleates two Snf7 homo-oligomers creating a ring 
or spiral that “encircles” the cargo129. After recruitment of Snf7, Snf7 oligomerizes to 
form rings, straight filaments or spirals of varying diameter129. However, Snf7 filaments  
are the best characterized129. Together, both Snf7 filaments and Vps24-Vps2 capping 
work together to deform the membrane surface. However, it still remains unclear about 
the mechanism used by ESCRT-III to narrow the ILV neck129. One theory is that Snf7 
oligomers are naturally curving the membrane in favor to the ideal diameter, and as 
oligomerization processes the filaments narrows the diameter and the diameter is 





 The second model is based with the implication that the Vps24-Vps2 subcomplex 
acts as a central mediator178. Lata and her colleagues observed Vps24-Vps2 cylinder 
staked as rings or spirals; then cylinders form tapered ends decreasing in diameter end 
ending into a “dome” shape129,178. Together, Snf7 filaments followed by Vps24-Vps2 
cylinder tapered ring stacking “capping”, forms rings or spirals decreasing in diameters 
inside the neck forming ILV179.  The dome mediating constriction of the ILV is 
determined by the protein affinity for the membrane, generating a curved membrane 
dome, which buckles to facilitate membrane scission129. Either theories, the Snf7 classical 
budding or the dome model, requires the recruitment of Vps4. 
 
Vps4-Vta1 Function in Membrane Scission 
Recent studies indicate that Vps4 might have other roles than to 
“recycle”/disassemble of ESCRT-III subunits after membrane scission180. Vps4 has been 
suggested to also have a role in the membrane scission process. In general, there are two 
hypotheses. One hypothesis involves Vps4-Vta1 complex to engage ESCRT-III 
following its assembly and provides the mechanical motor to help generate the 
constrictive forces needed for scission at the ILV neck129.  In detail, Vps4-Vta1 oligomers 
bind to ESCRT-III subunits and mediate a stepwise disassembly motion along the 
ESCRT-III polymer, which can generate the force needed to mediate the constriction of 
the polymer into smaller and smaller rings, known as the “purse string” model181. The 
second hypothesis proposes the disassembly by Vps4-Vta1 is more of an explosive 
dramatic event. Vps4-Vta1 oligomer engages multiple ESCRT-III subunits while 
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simultaneously mediating a concerted disassembly of ESCRT-III oligomers resulting in a 
drastic removal of the ESCRT-III complex129. The removal of the ESCRT-III complex at 
once might cause the ILV budding to destabilize the curved membrane leading to 






Table 1 - Table categorizing all ESCRT components in yeast and mammalian 
homologues. 
A table that categorizes all the components of ESCRT proteins into their prospective 






















Figure 1 - EGOC and TORC1 interaction schematic 
Schematic displaying the potential interaction between EGOC and TORC1 relaying 




Figure 2  
 
Adapted from McEwan and Dikic, 2011; Klionsky and Eskelinen, 2014  
 
Figure 2 - Macroautophagy schematic 






Adapted from McEwan and Dikic, 2011; Klionsky and Eskelinen, 2014  
 
Figure 3 - Nutrient rich vs nutrient poor environment within TOR and autophagy 
responses.  
Nutrient rich environments leads to a negative regulation of autophagy Atg1-Atg13 
complex by TORC1 phosphorylation. Phosphorylation on the Atg1-Atg13 complex 
prevents it interaction with Atg17-Atg29-Atg31 complex; thus, preventing the initial 







Figure 4 - Lipidated process of Atg8. 
Yeast Ubiquitin-like conjugated signaling pathway. Atg8 is initially cleaved by Atg8 
resulting in the processed form of Atg8. Active form of Atg8 then binds to Atg7, which 
activates the process from of Atg8 to initiate the transfer to Atg3. Atg3 is responsible for 
creating a platform for formation of a covalent bond between PE and Atg8; thus, 
concluding to a lipidated (conjugated) Atg8 form. This process is yeast representation of 




Figure 5   
 
Figure 5 - Summary of all ESCRTs functions. 
Summary of ESCRTs dynamic ability in different cellular processes, ranging from 




Figure 6  
 
Figure 6 - ESCRT-II diagramed protein structure. 
ESCRT-II forms a unique Y-shaped protein structure. Vps22 (hEAP30) and Vps36 
(hEAP45) create the base for the Y-structure, Vps25 (hEAP20) create the two arms of the 







Chapter 2  
Evidence ESCRTs may mediate the link between nutrient 
sensing and autophagy through the TOR pathway 
 
 
 Introduction  
 
My thesis project was derived from the results of a high throughput screen of the 
yeast knock out collection to identify novel regulators of cell death, amino acid sensing 
and the TOR pathway by the Hardwick lab182. The yeast knockout collection is a 
collection of about 5,000 yeast strains with single gene deletions (knockouts) of non-
essential genes. Earlier studies in our lab revealed that the cell death-sensitivity and 
amino acid sensing-defective phenotypes of ∆fis1 strain were not a direct consequence of 
FIS1 deficiency, but instead were due to an acquired secondary mutation within WHI2 
gene182,183. The phenotype caused by the secondary mutation was over growth in low 
amino acids conditions compared to wild type182. However, three of four independently 
derived ∆fis1 strains had also acquired unique secondary mutation in the WHI2  
gene182,183. When functioning properly, cellular proliferation should be inhibited under 
conditions of low amino acids. Low amino acids triggers inactivation of TOR/mTOR, 
which relieves the suppression by TOR/mTOR on autophagy resulting in autophagy 
initiation. Therefore, this relationship between autophagy and nutrient-sensing is key for 
proper cellular function. This overgrowth phenotype and sustained Tor activity of the 
whi2 mutant strain implies a role for WHI2 in either amino acid sensing negative 
regulation of TOR or induction of autophagy184,185 suggests that the possible dysfunction 
is either amino acid sensors or TOR regulators182. Therefore, our lab conducted a 
genome-wide screen for strains that exhibit strong overgrowth phenotypes on low amino 
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acid medium to search for potential regulators of nutrient sensing.  Screening the yeast 
knockout collection led to the discovery of 751 yeast strains with the overgrowth 
phenotype182. Two additional parameters were included in the same overgrowth screen in  
yeast cell death (heat ramp assay) and sensitivity of the low amino acid overgrowth to 
rapamycin182,186. They reasoned that the cell death/survival and growth control are 
perhaps the most important determinants for driving genome evolution. Therefore, they 
applied heat to yeast strains as a source of stress to induce cell death, and to assess the 
role of TOR in the overgrowth phenotype, they simultaneously screened with 182. These 
studies identified 259 different knockout strains among the 751 that shared all three 
phenotypes of WHI2 mutants. The strains with this whi2-like, “triple phenotype group”, 
are  heat ramp-sensitive, overgrowth on low amino acids, and this overgrowth is 
rapamycin sensitive182,183.  Further genetic analysis divided this group of 259 “whi2-like” 
triple phenotypes into two subgroups, those with triple phenotypes due to the knockout 
gene itself and those with triple phenotypes due to a  secondary mutation 182. The 
remaining members of the 751 group contains,  492 knockout strains with overgrowth on 
low amino acids, but without heat sensitivity, and/or rapamycin resistant-overgrowth182. 
Strikingly, these 492 strains were enriched in ESCRT genes, with 13 of the 14 core 
components of the ESCRT pathway, when deleted, exhibited low amino acid overgrowth 
(Figure 7).  The one ESCRT component that was not captured by the yeast screen, 
∆hse1, which could possibly have its overgrowth phenotype masked by secondary 
mutations. For example, overgrowth of ∆atg6 is caused by the loss of ATG6 itself, but a 
secondary mutation restores the overgrowth phenotype back to the normal (slower) 
growth phenotype182. The results from this screen are diagrammed in (Figure 8).  
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In conclusion, we know that Whi2 must be necessary for nutrient sensing and/or 
for responding to low nutrients. Therefore, the other 492 are potential candidates for 
factors working in the same pathway. It is important to understand the significance of this 
group by its capturing of 13/14of the ESCRT core components.  Therefore, I investigated 
the role of ESCRTs in nutrient sensing and potentially. It known that there is a link 
between TOR and autophagy in mammals and yeast. In addition, there is evidence in 
mammals for the involvement of ESCRTs in autophagy, but this is not yet reported in 
yeast112. However, there have been suggestions that ESCRTs are involved in the TOR 
pathway, but the evidence thus far is weak187,188.  My research is based on uncovering 
ESCRT interaction with TOR pathway and autophagy within yeast. 
 
Material and Methods 
 
Yeast Strains and Media 
All yeast strains used have a BY4741 background (Appendix i).  YPD liquid 
medium recipe contained 2% peptone (Peptone-Y, MP Biomedicals), 1% yeast extract 
(Fisher Scientific) and 2% glucose (Fisher Scientific). YPD agar plate were made by 
adding 2% agar (BD) in the existing liquid YPD medium recipe.  
All low amino acid liquid medium and dropout liquid medium contained 0.67% 
of yeast nitrogen base without amino acids (MCP), 0.2% glucose (Fisher Scientific), and 
0.62 grams dropout mix for SCD ME and 1g amino acid dropout mix for all other dropout, 
selective, media (Table 2).  Low amino acid liquid medium and selective media agar 




Tetrad Dissection and Tetrad analysis 
Tetrad Dissection 
Tetrad dissections began with a backcross the strain of interest from the yeast 
knockout collection (BY MATa, BY4741 background) with wild type BY4742 (MATα) 
on rich media agar plates (YPD plates) and incubated at 30°C overnight (Figure 9).  The 
diploids were then selected on a selection plate (SCHcsh-MET-CYS-LYS) that incubated 
at 30°C for 2 days. A single colony from diploid strain was picked to be inoculated in 
2ml of YPD liquid medium and incubated at 30°C overnight. The overnight cultures were 
then diluted to OD600 of 0.2 in 2ml of fresh YPD and incubate at 30°C until reach mid-
log phase with an OD600 ≅ 0.5 to recover the yeast. Yeast cells were then centrifuged at 
13,000 RPM for 1 minute, washed with sterile ddH2O, and resuspended in 2ml 
sporulation medium (1g/100ml potassium acetate, 50nM uracil, 50nM adenine, 75nM 
histidine and 500nM of leucine). Yeast were further incubated on rotator at room 
temperature for at least 4 days to allow for efficient sporulation. Although, this 
incubation might vary depending on the sporulation efficiency of the yeast strain. After 
efficient sporulation, 100µl yeast samples were centrifuged at 13,000 RPM for 1 minute 
and resuspended in 100µl of 1 M sorbitol. In order to digest yeast cell wall 3µl of 
zymolyase stock solution (20mg/ml in 1M sorbitol) was added and then incubated in 
30°C water bath for 5 minutes. The digested samples were then diluted 1:3 in 1M of 
sorbitol and streaked on an YPD plate with sterilized metal loop. Tetrads were then 
dissected using a glass fiber needle under a microscope (Axisoskop 40, 10X objective 
lens) and 4 spores were placed individually on the same YPD plate. After plating the 
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individual tetrad spores, the tetrad plate was incubated for 2 days at 30°C to allow the 
spores to grow into colonies.  
The tetrad spores were then genotyped by plating on selective media. First, spores 
were inoculated in 200µl YPD in 96-well plates for 48 hours. Tetrad verification was 
completed by spotting 3µl of liquid cultures on the following plates SCDcsh-MET-CYS 
and SCDcsh-LYS to assess auxotrophic markers and YPD + G418 plate to verify KanMX 
cassette (knockout gene replacement). Then mating types were then identified by 
crossing strains with 3µl of tester-MATa and tester-MATα strains, which were then 
replica plated on SD plates.  Yeast plated on SCDcsh-MET-CYS and SCDcsh-LYS and 
YPD + G418 plates were incubated for 1 day at 30°C and scored for growth. Replica 
plates were incubated for additional day at 30°C and then scored. Then spores were tested 
for triple assay (Heat Ramp, low amino acids +/- rapamycin) to analyze the genetic 
linkage between phenotypes and the knockout gene.  
 
Heat-ramp cell death assay 
Heat-ramp cell death assay developed my Xinchen Teng was used to ascertain the 
yeast sensitivity to a death stimulus upon tetrad spores186. The tetrad spores were then 
incubated in YPD for 48 hours incubated and the incubated tetrads liquid culture was 
diluted 10-fold. After the 10-fold dilution, the culture was then heated by thermocycler at 
a continuous heat ramp for 20min from 30°C to 62°C. 5µl of the treated cultures were 
spotted on YPD square plate at 1:1 dilution (the initial 10-fold dilution) and an additional 
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1:5 dilution. This plate was then incubated at 30°C for 2 days and scored for levels of 
growth. After the 2 day incubation, images were then obtained of each plate for archives.  
 
Low amino acid +/- rapamycin assay 
After the 48 hr incubation of tetrad spores in liquid YPD, the liquid culture was 
diluted 1:10 and 1:50 with ddH2O. 5µl of diluted yeast were spotted on low amino acid 
medium (SCDME) and low amino acid medium with 2.5nM rapamycin plates. Both plates 
were then incubate 30°C for 3 days and scored for levels of growth. After the 3 day 
incubation, images were then obtained of each plate for archives.  
 
Yeast Transformation 
ESCRT mutant strains transformed with GFP-Atg8 plasmid was conducted by the 
following method. First, grew an overnight yeast culture of mutant strain in 2ml of YPD, 
14 – 15 hours. Diluted the liquid cultures to OD600 of 0.25 OD per sample into 2ml of 
YPD and incubated at 30°C for 3-4 hours. Then centrifuged 1ml of yeast culture at 
13,000 RPM for 1 minute, washed once with 0.1M LiAc, and resuspended with 100µl of 
LiAc. Next, I prepared denatured salmon sperm DNA (ssDNA) by boiling at 100°C for 5 
minutes and then placed on ice. Then added 1-2ug of plasmid DNA to yeast sample. In 
addition, added 5µl ssNDA to sample. Finally, I added 350µl of transformation plate mix 
to yeast sample. After mixing all the reagents with the yeast samples, then incubated 
eppendorf cultures onto rotator for 30 minutes 30°C. After incubation, heat shocked yeast 
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cultures for 10 minutes at 42°C in water bath. Then centrifuged the yeast samples at 
13,000 RPM for 1 minute, resuspended yeast in 100µl of water. Lastly, plated 100µl of 
yeast onto selective yeast plate and then spread. Incubated plates into a 30°C incubate for 
2 days.  
Optimized Autophagy Assay  
To start the optimized autophagy assay began by inoculating 3 yeast colonies per 
sample into 3ml of SCDCSH-URA media, which was then incubated overnight for 14hrs – 
17hrs, on the rotator in 30°C.  Then overnight cultures were diluted into two different sets 
of yeast cells, set 1 to OD600 of 1 and set 2 OD600 of 1.2.  Set 1 was then centrifuged at 
13,000 RPM for 1 minute and stored the pellet at -20°C. Set 1 is labeled as the overnight 
yeast culture sample. To recover the yeast after their overnight incubation, set 2 yeast 
samples were also centrifuged set 2 yeasts sample at 13,000 RPM for 1 minute, but then 
were resuspended with 6ml of SCDCSH-URA and incubated on rotator at 30°C until reached 
log phase, OD600 ≅ 0.5. After the recovery incubation, required 4 sets per 1 sample and 
set was calculated to have the volume equivalent to an OD600 of 1. Then the sets were 
centrifuged at 13,000 RPM for 1 minute and the yeast supernatant was aspirated. Out of 
the 4 sets, set 1 sample was centrifuged and stored pellet at -20°C. However, set 2,3,4 
were resuspended in 2ml of SCDME-URA and incubate on rotator at 30°C for various time 
points. Set 2 was incubated at 30°C for 1 hour. Set 3 incubate at 30°C for 2 hours. Set 4 
incubate at 30°C for 3 hours. After the incubation, the volume of yeast samples were 
obtained and were equivalent to an OD600 of 1 per sample. Each set samples were 
centrifuged at 13,000 RPM for 1 min; then aspirated the supernatant and froze down the 
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remaining pellet at at -20°C. The yeast were kept stored at -20°C until the preparation of 
western blot lysates. Each strain tested will end up having 5 different time points (Figure 
10).  
 
Preparation of Yeast Cell Lysates 
Autophagy assay samples were prepped for western blot by the following cell 
lysate method. The yeast samples were prepared for lysates at 1:1 ratio of the optical 
density to SDS page lysis loading buffer. The total amount of lysis buffer was aliquoted 
during the preparation, which was rounded to the nearest whole number. Then added 
protease inhibitor and phosphatase inhibitor diluted to 100X to the total volume of 
aliquoted loading buffer. Next, BME was added to total lysis loading buffer at a final 
concentration of 5%. The prepared loading buffer was mixed and resuspended each 
sample with equal amounts of lysis buffer to OD. After adding the prepared lysis loading 
buffer, half the sample volume with glass beads. Each sample was then vortex sample at 
max for 4 sets of ON 45 secs and OFF 30-45 secs with resting on ice in between 
vortexing sets. Then samples were incubated samples at 100°C water bath for 5mins. The 
finished prepared western lystates were then loaded onto 12% SDS gel with 10µl of 
sample and 5µl of standard marker. Western blotting procedures were then conducted to 
ascertain protein expression. The primary antibodies used were rabbit anti-GFP 1:500, 
rabbit anti-pS6 at 1:1000, and mouse anti-PGK 1:5000. The secondary antibodies’ used 





Tetrad Dissections  
A significant portion of yeast knockout strains were found to have a secondary 
mutation responsible for their overgrowth on low amino acids 182. However, the evidence 
also indicates that acquisition of a secondary mutation is a consequence of losing the 
specific function of the original knockout gene. Nevertheless, to determine if ESCRTs 
themselves are required for restricting growth on low amino acid medium, it was 
necessary to perform genetic analyses to identify any potential secondary mutations.  
To determine if ESCRT knockout strains fail to appropriately slow their growth 
on low amino acid medium compared to wild type because of their ESCRT deficiency or 
because of a secondary mutation, I performed tetrad analyses to segregate any potential 
secondary loci. One knockout strain for each of the ESCRT complexes was backcrossed 
to wild type and sporulated. Each tetrad was dissected and analyzed for genotype and 
phenotype (Figure 9)189. A dissection is conducted on a single meiotic event by breaking 
the four haploid spores, therefore two of the four spores will carry the knockout gene 
(identified based on G418 resistance). After confirming true tetrads based on known 
markers of the two parental strains, these same spores were then analyzed for three 
phenotypes of interest (overgrowth on low amino acids, heat-ramp sensitivity/resistance, 
and the effects of rapamycin on the overgrowth phenotype). To draw firm conclusions, 7-
12 tetrads were analyzed for each strain. The results of these tetrad analysis clearly 
demonstrates that all the ESCRT knockout strains had low amino acid overgrowth that 
consistently segregated with the knockout locus, indicating that the ESCRT gene deletion 
was responsible for overgrowth and not a secondary mutation (Table 3, Appendix i, 
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Appendix ii, Appendix iii). Because all tested ESCRT knockout strains behaved 
similarly, and because each ESCRT is a multimeric complex as explained above, we can 
reasonably conclude that the low amino acid overgrowth phenotype of the other ESCRT 
subunit gene knockouts would yield similar results. However, it is interesting to note that 
the true cell death phenotype of ESCRT knockouts strains is that cause increased 
sensitivity to heat-ramp treatment (Appendix iii). Thus, there is a secondary mutation 
that confers cell death resistance, explaining why the parental ESCRT knockout stains 
have heat ramp-resistant phenotype (Appendix iii). Substrains of tetrad spores were 
relatively heat sensitive phenotype compared to WT, but greater growth than ∆whi2 heat 
sensitivity phenotype.  
 
Autophagy Assay 
To determine if ESCRTs are important for autophagy induced by low amino acid 
conditions. I transformed the ESCRT knockout strains with a plasmid expressing a GFP-
Atg8 fusion protein (Figure 11, Appendix i). This reporter can detect autophagy 
induction as it is under the control of ATG8 promoter, which is induced upon activation 
of autophagy (provided by Jodi Nunnari)190. The transformation of this plasmid also 
allows for the detection of autophagy flux by tracking the degradation of the Atg8 moiety 
and liberation of the more protease-resistant GFP portion in the yeast vacuole.  To induce 
autophagy in the transformed yeast, an overnight culture of yeast was subjected to 
nutrient deprivation via incubation in low amino acid medium (SCDME-URA), known as 
the autophagy assay. In the same lysates, I also analyzed TOR kinases activity via the 
phosphorylation of ribosomal protein S6 (pS6).  The autophagy assay used in the western 
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blots was optimized from the original autophagy assay used in our lab because the 
original autophagy assay used yeast at the post-diauxic growth phase many hours after 
switching to low amino acid medium. Furthermore, high density cell cultures of different 
strains could have the ability to consume key nutrients in the medium at different rates 
which may mimic an autophagy result. Therefore, I optimized this assay to exclude 
outside influences by restricting the yeast to their log phase and using shorter treatment 
times. These low density cultures also prevent the yeast depleting the medium.  
 
ESCRT I and II – analysis of Srn2 and Snf8  
Tor activity 
 Nutrient withdrawal was conducted on knockout yeast strains lacking subunits of 
ESCRT-I and ESCRT-II. srn2∆ (ESCRT-I) and snf8∆ (ESCRT-II) transformed with the 
ProATG-GFP-Atg8 plasmid. Each transformed ESCRT strain subjected to nutrient 
withdrawal (SCDME-URA) (Figure 10). Yeast lysates of 1OD600 were collected from each 
time point during the autophagy assay, including the starting overnight (O/N) culture, 4 
hr recovery in YPD, then  switching to 1, 2 and 3 hr in low amino acid medium (SCDME-
URA), Lysate were prepared for western blots using anti-pS6 (see methods). Tor activity 
was measured using a phosphorylation-specific antibody directed against mammalian 
phosphor-S6, which cross reacts with yeast pS6 due to high conservation185. pS6 was 
detected by anti-pS6rabbit and phosphoglycerate kinase (PGK), major glycolysis enzyme, 
was used as a loading control. 
 As expected, WT Tor activity during following autophagy induction decreased as 
time progressed in the low amino acid medium incubation (Figure 12). Deletion of SNF8 
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caused a decline in Tor activity similar to that of WT (Figure 12A, B). Therefore, Snf8 
of ESCRT-II does not appears to be a negative regulator of TOR, in contrast to Whi2 184. 
In contrast, the deletion SRN2 subunit of ESCRT-I exhibited sustained Tor activity in low 
amino acids (Figure 12 A, B). This is based on the pS6 levels during low nutrient 
conditions. srn2∆ sensing low amino acids reaction was slower that the sensing abilities 
of snf8∆ and WTα, represented by the minor decrease in Tor activity. Potentially, 
resulting in a nutrient sensing defect/TOR dysfunction.  
To confirm that the deletion of SRN2 results in the low amino acid overgrowth 
and sustained Tor activity, I tested a srn2∆ haploid spore from the tetrad dissections 
described below.  This srn2∆ haploid tetrad spore has a phenotype of heat sensitive, 
overgrowth on low amino acid, and has rapamycin-resistant overgrowth. srn2∆spore was 
tested in the autophagy assay against a positive control, whi2∆, and negative control, 
WTα. srn2∆ haploid spore, whi2∆, and WTα were transformed with GFP-Atg8 plasmid. 
However, this time the WTα did not depict the normal protein profile of pS6 during low 
amino acid condition (compare Figure 12 and Figure 13). Initially there was a decrease 
in pS6 levels from 1 hour to 2 hours, but then rises from hour 2 to hour 3. This is not a 
typical Tor activity in WTα strains. This profile was only seen once in the total of three 
times the autophagy experiment was run. Although this was the only experiment in my 
experience where the wild type did not behave as expect, thereby compromising my 
conclusions for the ESCRT knockout strains, the Western blots results suggest that there 
is a delay in nutrient-sensing in srn2∆ (ESCRT-1) (Figure 12 A, B and Figure 13 A, B). 
In fact, western blots revealed there was an increase of Tor activity through times points 




 WTα, srn2∆ and snf8∆ yeast lysates of 1OD600 were collected from each time 
point during the autophagy assay. Lysate were prepared for western blots using anti-GFP 
antibody (see methods). Autophagy activity was measured through the protein levels both 
the conjugated form GFP-Agt8 and free GFP.  Western blots revealed that there was a 
presence of both forms, Atg8-GFP and free GFP, during the autophagy assay (Figure 12 
C, D). In addition, there was a high background level. Therefore, the data is inconclusive 
and results might be an artifact. On the other hand, presences of both forms can be due to 
an autophagy flux or a lysosome dysfunction.  
 The second set of transformed yeast WTα, srn2∆ tetrad spore, and whi2∆ yeast 
lysates were collected the same way. The autophagy activity was similar to the previous 
transformed yeast, presences of both GFP forms. But western blots revealed that there 
was high expression of GFP-Atg8 during time points of WT, but GFP-Atg8 expression 
was lost in srn2∆ tetrad spore and whi2∆ (Figure 13 C, D). Although whi2∆ lacked 
expression of GFP-Atg8, there was presence of GFP maybe concluding to an induction of 
autophagy. It is interesting to note that wild type has expression of both GFP-Atg8 and 
GFP, both induction and flux is occurring. However, there was a high protein background 
level.  In conclusion, the data still remains inconclusive.  
 
ESCRT-0 and III – analysis of Vps27 and Snf7 
Tor activity  
Nutrient withdrawal was conducted on knockout yeast strains lacking subunits of 
ESCRT-0 and ESCRT-III. vps27∆   (ESCRT-0) and snf7∆  (ESCRT-III) was transformed 
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with ProATG-GFP-Atg8 plasmid. Each transformed ESCRT strain was subjected to 
nutrient withdrawal (SCDME-URA) at three different time points. Yeast lysates of 1OD600 
were collected from each time point during the autophagy assay, including the starting 
overnight (O/N) culture, 4 hr recovery in YPD, then  switching to 1, 2 and 3 hr in low 
amino acid medium (SCDME-URA). Lysate were prepared for western blots using anti-pS6 
(see methods). Tor activity was using a phosphorylation-specific antibody directed 
against mammalian phosphor-S6, which cross reacts with yeast pS6 due to high 
conservation185. pS6 protein was detected by anti-pS6rabbit And phosphoglycerate kinase 
(PGK), major glycolysis enzyme, was used as a loading control.  
As expected, wild type Tor activity during the autophagy decreased as time 
progressed in the low amino acid medium incubation. vps27∆ Tor activity showed the 
traditional phenotype, decreased of pS6 expression during times in SCDME-URA medium 
like WTα. However, western blots revealed a different protein expression profile for 
snf7∆. Tor activity, pS6, continued to increase in low amino acid medium up to 2 hrs of 
incubation (Figure 14 A, B). After 2 hours incubation in SCDME-URA medium Tor activity 
begins to decrease.  Results are interpreted as a nutrient delay/TOR dysfunction.  
 
Autophagy activity  
 WTα, vps27∆, snf7∆ yeast lysates of 1OD600 were collected from each time point 
during the autophagy assay. Lysate were prepared for western blots using anti-GFP 
antibody (see methods). Autophagy activity was measured through the protein levels both 
the conjugated form GFP-Agt8 and free GFP.  Western blots revealed that there was a 
presence of both forms, GFP-Atg8 and free GFP, during the autophagy assay throughout 
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all the time points. (Figure 14 C, D).  However, detection of free GFP was faint in all 
samples, but was most prominent in overnight samples of vps27∆ and snf7∆, which may 
present a lack of autophagy induction.   Overnight WTα sample expresses only minimal 
protein expression a sign of autophagy induction. There was high background level 
within the blot. Therefore, data is conclusive, but the prominent appears of the 
background from three trials could be a true result. Perhaps there is a lysosome 
dysfunction, cargo attachment, or that not all the protein is being broken down during 
lysate preparation.  
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Table 2  
 
Adapted from Maragret Dayhoff 
Table 2. Media recipe for rich media and low amino acid media. 
Media recipe for rich media and low amino acid media. 
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Table 3    
 
Notes:       
Rap^R* - analysis descripencies based on poor growth on 5 nM concentration  
MDB – performed by PhD student, Margaret Dayhoff-Branningan 185   
 
   
Table 3 - Summary of ESCRT components and correlating phenotypes through 
tetrad dissections. 
Table of ESCRT components that have had the phenotypes of the spore-derived 





Figure 7   
 
Figure 7 - Overgrowth phenotype in low amino acid conditions. 
Overgrowth phenotype on low amino acid medium compared to YPD (rich) medium. 1:4 
serial dilutions at 20µl yeast: 80µl dH2O. Knockout strains are representative of each 





Figure 8   
 
Figure 8 - Flow chart of yeast knockout collection screen. 
Schematic of the genetic yeast knockout collection screening results for sensors of low 
amino acids. Red text indicates the location of ESCSRT knockout strains within the 
genetic screen flow chart. In red, distinguishes the location of ESCRTs within the genetic 




Figure 9   
 
 
Figure 9 - Schematic of a tetrad dissection. 
Schematic of a tetrad dissection genetic process to confirm the origination of the 
phenotype. Haploid strains are then plated on YPD plates to grow. Haploids are the 
subjected to heat, low amino acid conditions, and low amino acid conditions with 















Figure 10 - Schematic of autophagy assay. 
Schematic of the log-phase restricted autophagy assay.   
SCDCSH medium 
overnight 
4 hour re-feed 
 in SCDCSH medium.  
0.2 OD600 –  ~0.5OD600 
1 hour 
sample 











Figure 11    
 
Adapted from McEwan and Dikic, 2011; Klionsky and Eskelinen, 2014  
 
Figure 11 – Plasmid reporter autophagy assay.  
Yeast transformed with prATG8 GFP-ATG8 plasmid to track autophagy activity. Atg8 is a 
core lipidated autophagy protein marker for active autophagosomes. During autophagy, 





















Figure 12 - ESCRT-I and ESCRT-II Tor and autophagy activity. 
Unfortunately, not all collected lysates were run due to the limited number of wells per 
comb, which excluded 4hr recovery sample of Snf8 for both TOR activity and autophagy 
activity. A) Western blot of TOR activity through phospho-s6 (anti-pS6 1:1000), PGK 
(anti-PGK 1:5000) loading control. 30 second exposure. Comparison of collected 1OD 
yeast cell lysates  (WTα, srn2∆ (BY MATa), and snf8∆ (BY MATa) transformed with 
Atg8-GFP plasmid at various time points overnight (O/N), 4hr rich-media recovery, 1hr 
low amino acids, 2hr low amino acids, 3hr low amino acids. * 4hr recovery time point is 
excluded due to space of blot. 1-3 hr (ME) time points were gathered after switching to 
low amino acid medium SCDME-URA. srn2∆ subunit expresses a potential delay in 
response to a low nutrient condition. B) Quantification of protein expression of WTα , 
srn2∆ (BY MATa), and snf8∆ (BY MATa) at normalized volume. n=1.  C) Western blot of 
autophagy activity measuring: Atg8-GFP and GFP. 30 second exposure. Presence of both 
forms (and large background bands) inhibits concrete data analysis upon autophagy 
activity; thus, data inconclusive. D) Quantification of autophagy activity. 
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Figure 13 - ESCRT-I (haploid spore) and WHI2 Tor and autophagy activity 
Unfortunately, not all collected lysates were run due to the limited number of wells per 
comb, excluded 4hr recovery sample of Whi2 for both TOR activity and autophagy 
activity. A) Western blot of TOR activity through Phospho-serine6 (anti-pS6 1:1000), 
PGK (anti-PGK 1:5000) loading control. 5 second exposure. Comparison of collected 
1OD yeast strains (WTα, srn2∆ Tetrad Spore, and whi2∆) transformed with Atg8-GFP 
plasmid at various time points overnight (O/N), 4hr rich-media recovery, 1hr low amino 
acids, 2hr low amino acids, 3hr low amino acids. * 4hr recovery time point is excluded 
due to space of blot. 1-3 hr (ME) time points were gathered after switching to low amino 
acid medium SCDME-URA. srn2∆ tetrad spore confirms that Srn2 subunit does have a delay 
in nutrient response. srn2∆ tetrad spore was taken from my previous tetrad dissection 
(Kan+, heat resistant, overgrowth, rapamycin resistant). B) Quantification of protein 
expression of WTα and srn2∆ (BY MATa) tetrad spore. n=1.  C) Western blot of 
autophagy activity measuring: Atg8-GFP (anti-GFP 1:5000) and GFP. 2.5 minute 
exposure. Presence of both forms (and large background bands) inhibits concrete data 





























Figure 14 - ESCRT-0 and ESCRT-III Tor and autophagy activity. 
Unfortunately, not all collected lysates were run due to the limited number of wells per 
comb; thus, excluded 4hr recovery sample of Vps27 for both TOR activity and autophagy 
activity. A) Western blot of TOR activity through Phospho-serine6 (anti-pS6 1:1000), 
PGK (anti-PGK 1:5000) loading control. 30 second exposure. Comparison of collected 
1OD cell lysates of WTα, snf7∆  (BY MATa), and vps27∆ (BY MATa) transformed with 
Atg8-GFP plasmid at various time points overnight (O/N), 4hr rich-media recovery, 1hr 
low amino acids, 2hr low amino acids, 3hr low amino acids. * 4hr recovery time point is 
excluded due to space of blot. 1-3 hr (ME) time points were gathered after switching to 
low amino acid medium SCDME-URA. snf7∆ subunit expresses a delay in response to a low 
nutrient condition. B) Quantification of protein expression of WTα , snf7∆ (BY MATa), 
and vps27∆ (BY MATa) at normalized volume. n=1 C) Western blot of autophagy activity 
measuring: Atg8-GFP and GFP. 30 second exposure. Presence of both forms (and large 
background bands) inhibits concrete data analysis upon autophagy activity; thus, data 




Discussion and future directions 
 
The cells ability to sense the cellular nutrient status, both externally and 
internally, in the environment is vital for the cell to sustain life. There is a direct 
correlation between the nutrient status and cellular proliferation. If the environment is 
nutrient rich, it cues the cell to initiate and promote cellular growth1. On the other hand, if 
the environment is unfavorable, then it cues the cell to halt proliferation and initiate 
autophagy1. The main nutrient sensor is TOR and is conserved throughout species2. TOR 
is responsible for relaying the nutrient availability to its downstream effectors to control 
both anabolic and catabolic processes, including inducing the switch from proliferation to 
degradation by autophagy3,5. Although, it still remains a mystery how TOR exactly 
senses nutrients and how it transduces the signal to its downstream effectors. However, 
my research may project new insights of possible candidates for the mechanism to sense 
nutrients, ESCRT complex. This projection is not only based on results, but based on 
previous findings. In particular, ESCRTs are known to be involved in autophagy112. 
ESCRTs create an alternative autophagy pathway by the formation of amphisomes 
vesicles (MVB fused with autophagosomes) that later merge with the lysosome for 
degradation in mammalians, but this was not observed in yeast112. In addition, researchers 
are exploring the idea that ESCRTs are involved in microautophagy117. Based on my 
preliminary results, possible ESCRT interaction with TOR signaling, and previous 
knowledge in ESCRTs involvement in autophagy might be the link that connects nutrient 




ESCRT involvement  
 My preliminary data suggest that there is possible involvement of the ESCRT 
machinery in sensing nutrients and transducing the information to TOR. I made it 
imperative to subject one subunit from each ESCRT complex to the autophagy assay to 
test the array of ESCRT complexes activity.  Although many ESCRT mutant strains 
weren’t tested, my experiments revealed that not all ESCRT complexes of the canonical 
pathway may be involved in sensing and relaying nutritional status to TOR.  The 
autophagy experiment provides a dual role. It tracks Tor activity and autophagy activity 
during nutrient deprived conditions. I created an optimized assay, which constricts yeast 
to their log phase, excluding any possible outside influence upon the results (Figure 10). 
  
Sustained Tor activity under deprived nutrition conditions and its implications in ESCRT 
involvement with nutrient sensing  
From tetrad dissections all mutant ESCRTs have an overgrowth, relatively heat 
sensitive, and rapamycin resistant phenotype, which was confirmed to be a result from 
the gene deletion of the yeast knockout collection. Therefore, all subunits have the 
potential to have a TOR defect and seem to be position upstream of TOR due it 
insensitivity to rapamycin. Analyzing the protein expression of these ESCRT strains 
during starvation time points discovered not all ESCRT components expressed a TOR 
defect.  After completing each time point and blot for Tor activity (pS6) and autophagy 
activity (GFP-Atg8) revealed that only two ESCRT subunits are potentially involved in 
relaying information to TOR. Out of the ESCRT strains tested, preliminary results could 
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reveal not all ESCRT components are required for nutrient signaling. srn2∆ and snf7∆ 
express high Tor activity during times of nutrient withdraw, which is in contrast to WTα 
(Figure 12, 13, 14).  Initially, srn2∆ only expressed a minimal decrease of TOR activity 
during nutrient withdraws in comparison to WTα. To further analyze the involvement 
srn2∆, I tested a haploid spore generated from a previous tetrad dissection against whi2∆ 
as a positive control. Discovered from previous lab members, whi2∆ is known to have 
increasing Tor activity during nutrient withdraw. Blots confirmed the occurrence of a 
nutrient signaling delay. Protein analysis resulted in a dramatic increase of pS6 
expression through all three time points, similar to whi2∆. Therefore, high Tor activity 
was maintained during nutrient withdrawal.  snf7∆ blots revealed an increase of pS6 
protein expression through the three time points of nutrient withdrawal, contrasting wild 
type. In conclusion, high Tor activity during nutrient withdrawal in srn2∆ and snf7∆ 
might conclude in a TOR defect  
It is known that Srn2 subunit of ESCRT-I is involved in sequestering 
ubiquintinated cargo along with ESCRT-0, but ESCRT-III is typical not known for cargo 
sequestration. The main responsibility of ESCRT-III is to form the machinery which 
creates invagination within the membrane to form the ILV of MVB. Perhaps, ESCRT-III 
does recognize cargo during its process of membrane invagination as a quality control 
check point.  Regardless, srn2∆ and snf7∆ possible defect projects the possibility of 
ESCRT-I and ESCRT-III in relaying nutrient status to TOR. I propose two different 
signaling pathways that require ESCRT machinery to complete its signaling relay to Tor, 
EGO complex signaling and calcium ER/Golgi signaling via TOR.  
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ESCRTs relay nutrient signals to TOR through EGO Complex 
Starvation conditions induces cell quiescence. When conditions are replenished, 
exiting G0 stage properly requires a protein complex called EGO29. EGO complex 
interaction with TOR is seen on both levels, EGO alone and in conjunction with the Gap1 
sorting from endosomes (GSE) complex37. Gap1, low specificity transport, is induced in 
nitrogen-limited environment and is sequestered by MVB when nutrients are 
replenished191. However an additional recycling trafficking step of Gap1 was identified, 
which competes with MVB sorting, GSE complex and GSE is highly identical with EGO 
complex37,192. Mutants in any components of the GSE/EGO complex fail to recycle Gap1 
to plasma membrane and have diminished recovery from rapamycin treatment37,192. EGO 
complex alone presents an interaction with TOR. EGO complex is localized on the 
vacuolar membrane enabling its sensing of intracellular leucine to TORC129. Leucine 
starvation results in a reduction of Sch9 dephosphorylation due to the destablization of 
Gtr1-TORC133. The interaction of EGO with TOR also due to its location and its 
phosphorylation reduction of Sch9 presents EGO complex as a major upstream regulator 
of TORC1 (see Figure 1). But what remains to be unknown is the mechanism of EGO 
complex uses to sense amino acid29. 
 
 EGO complex is comprised of Ego1, Ego3, Gtr1, and Gtr229.  Gtr1 and Gtr2 
belong to a family of Fas-GTPases193,194.  Gtr1 or Gtr2 is activated when bound to GDP 
permitting its TORC1-stimulating conformation33,193–195.  Ego1 is responsible to tether 
EGO complex to the vacuolar membrane because it is N-terminal and is mryisolated and 
palmitoylated28. Ego3 functions still remains a mystery, but it known to form 
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homodimers similar to Gtr1 and Gtr228.  Gtr1 GTPase activity is negatively regulated by 
the SEA complex (SEAC), specifically through a subcomplex called SEACIT (SEAC 
subcomplex Inhibiting TORC1 signaling)28.  SEACIT is composed of Iml1, Npr2, and 
Npr328. Leucine deprivation triggers Iml1 to interact with Gtr1 to inhibit TORC128. In 
addition, experimental data supports SEACIT responds to vesicle trafficking, amino 
acids, and leucine cues28. SEACIT is then negative regulated by SEACAT (SEAC 
subcomplex Activating TORC1 signaling)28.  
Based off the information previously stated, there are two theories that presents 
itself. Firstly, since it is know that recycling of Gap1 uses MVB in nitrogen starvation 
conditions, it could be possible that EGO complexes uses MVB to sense amino acids to 
relay its information to TOR. Based on the location of EGO complex and ∆srn2/∆snf7 
phenotype, puts both protein complexes upstream of TORC1. Together, EGO complex 
with their leucine starvation phenotype and srn2∆ and snf7∆ phenotype, I propose that 
ESCRT machinery could be the potential mechanism to relay amino acid levels from 
EGO complex to TOR pathway (Figure 15a). Secondly, perhaps it is not a direct 
interaction between MVBs and the EGO complex, but through SEACIT, since it is the 
ultimate negatively regulator of TORC1 through Gtr1 (Figure 15b).  Alternatively, the 
loss of ER/Golgi Ca2+/Mn2+ ATPase Pmr1 not only increases protein secretion through 






ESCRTs relaying nutrient signals to TOR correlating with ER/Golgi calcium levels 
An alternative pathway that possibly uses ESCRT machinery is the coordination 
of amino acid levels with calcium levels of ER/Golgi to TOR pathway through Pmr1. 
Like amino acids, calcium is another essential nutritional factor for organisms, which 
regulates growth, proliferation, cell death and muscle contraction187,197,198. Calcium 
homeostasis is critical for organisms and maintenance of calcium concentration requires 
regulation on calcium transporters and sequesters in plasma and organelle 
membranes187,199–201.  Transient increase of calcium from induction of vacuolar pump 
Pmc1, and the ER/Golgi Ca2+ pump Pmr1 is a critical stress response that is activated by 
the calcium/calcineurin signaling202,203.  A genome-deletion screen of S. cerevisaie strains 
identified ∆pmr1 as rapamycin resistant, which is a similar phenotype to my ESCRT 
knockouts (Table2) 188. Pmr1, ER/Golgi Ca2+/Mn2+ pump, functions in the secretory 
pathway for protein glycosylation, protein sorting, and ER protein degradation188,204. It 
was further inferred that due to its rapamycin resistant phenotype in ∆pmr1, presents 
Pmr1 as a negative regulator via opposing Lst9 in TORC1 signaling188. Thereby, 
suggesting Pmr1-dependent Ca2+/Mn2+ ion homeostasis is necessary for TOR 
signaling188.  
Zhao and his colleagues observed ESCRT deletion mutants of ESCRT-I subunits 
(stp22∆, vps28∆), ESCRT-II (snf8∆, vps25∆, and vps36∆), and ESCRT-III (nf7 ∆ and 
vps20∆) renders them calcium-sensitive due to accumulation of intracellular calcium ions 
in response to calcium stress187. Interestingly, they also noticed ESCRT mutants contain a 
reduced expression of PMR1 via the reduction of lacZ activity by half compared to wild 
type187. Calcium sensitivity in ESCRT mutants was completely suppressed by 
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overexpression of PMR1187. It is known that Rim101 is a transcriptional repressor, which 
is active in its short-length form and inactive in its full-length form187. ESCRT mutants 
only contain Rim101 in its inactive full-length form and this proteolytic defect is 
responsible for the calcium hypersensitivity in ESCRT mutants187. In conclusion, it is 
surprisingly to see ESCRT mutants with calcium/calcineruin signaling activated 
(hypersensitivity) have a reduction of PMR1 because PMR1 is a positively regulated by 
calcium/calcineurin signaling, which was due to the defective proteolytic cleaving of 
Rim101 in ESCRT mutants187,205. Therefore, proper ESCRT machinery provides another 
positive role in signaling transduction within calcium signaling, in addition to its positive 
influence upon the Wnt signaling80. In conclusion, combing evidence of Pmr as a 
negative TOR regulator and decrease PMR1 expression in ESCRT mutants, can link 
Pmr1 with ESCRT components to the expression or modification/sorting in ER/Golgi 
secretory pathway of nutrient transporters – coordinating calcium signaling with TOR 
(nutrient sensing) pathway in cells187.   
 Since my ESCRTs candidates are also known to be resistance to rapamycin along 
with Pmr1, it is logical to think that they might interact and maybe also be upstream to 
TOR. I also investigated the phenotype that was found in our labs yeast screen of Pmr1 to 
be heat sensitive, overgrowth, and rapamycin resistant. All three of these phenotypes 
match the substrain ESCRTs phenotypes, which adds additional strength to possibly 
place the ESCRT candidates in the same pathway as Pmr1-TOR.  Next, research just 
uncovered that ESCRTs have a role in regulating Pmr1 protein expression, presuming 
leading to negative regulation of TOR187,188. However, there was lacking experimental 
evidence observing the TOR activity within these ESCRT mutants in the study by 
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Zhao187. In fact, it was observed that ESCRT-I (Stp22, Vps28) and ESCRT-II (Snf7, 
Vps20) mutants to have a decreased Pmr1 expression. Perhaps, my mutant candidates, 
srn2∆ & snf7∆, containing high Tor activity might confirm their Zhao et al. findings in 
connecting ESCRTs with Tor activity and Pmr1187,188. However, not all components of 
the ESCRT seem to be required to translate to the TOR pathway.   Besides this fact, this 
pathway represents the prime avenue for ESCRT machinery in the relaying of nutrient 
status to the TOR pathway (Figure 16).  
 
Possible implication of ESCRT involvement based of its autophagy activity 
 At this point in the investigation, it is hard to definitely conclude any theories 
based on the occurrence of high background and possible autophagy reflux results. 
However, the re-occurrence of this autophagy phenotype might speak for itself. It is 
possible that high background might be due to some cellular dysfunction. During the 
analysis, when excluding the background bands, the presence of both forms GFP-Atg8 
and free GFP might give an insight on autophagy system within the ESCRT mutants. As 
mentioned earlier, researchers are uncovering ESCRTs involvement in macroautophagy 
through their involvement in formation of amphisomes in mammalian cells112. ESCRT 
mutants lead to the accumulation of amphisomes and autophagosomes112. However, this 
is not the case for all higher eukaryotic organism, like C. elegans. In fact, ESCRT 
mutants in C. elegans express and intact autophagy system, but presents both forms of 
Atg8; thus, resulting in an autophagy flux rather than accumulation of 
autophagosomes112. Perhaps, this is mimicking what occurs in my ESCRT mutants.  
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 Another explanation for this “reflux” could due to microautophagy rather than 
macroautophagy. Microautophagy, endosomal microautophagy, involves direct 
invagination of the vacuolar membrane29,49. Research in mammalian cells are uncovering 
the role of ESCRTs involvement in microautophagy. Current research presents that the 
endosome microautophagy selectively delivers specific cytosolic proteins to the vesicles 
of the late endosome during MVB biogenesis117. It is easier to comprehend a role for the 
ESCRTs in microautophagy. ESCRT-III complex will, most likely, be the most important 
complex in this system due it is responsibility in deforming the membrane to create 
membrane invaginations. This contradicts current knowledge of endosomal- 
microautophagy relying on ESCRT-I, ESCRT-II, Vps4 components for MVB 
formation117. However, perhaps, we are not seeing a clean turnover form GFP-Atg8, 
might be due its possible involvement in microautophagy, rather than macro-autophagy.  
 
Future Direction 
 The future direction of this project involves the analysis of the rest of the ESCRT 
components in the autophagy assay in addition to Snf7-stabilizing protein, Bro1. More 
importantly, the focus of the experiment should shift to protein interaction studies, 
especially when snf7∆ is resulting in a nutrient signaling delay. Is Snf7 sequestering 
amino acids in addition to its main function of creating membrane invagination? I would 
then execute immunopercipitate experiments with Snf7. I would want to see if it interacts 
with Srn2, since that is the other ESCRT subunit that expresses a nutrient signaling delay. 
Then I would want to test if there is an interaction with Pmr1, since that is a known 
negative TOR regulator and has the same Hardwick yeast screen phenotype as the 
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ESCRT mutants, and to observe if there is a direct protein interaction besides its 
influence upon its negative regulator Rim101/Nrg1 pathway. More importantly, is to test 
the protein interaction of both Srn2 and Snf7 with Whi2, important strain in discovering 
the overgrowth phenotype.  
Lastly, I would try investigating the specific amino acids are Srn2 and Snf7 are 
sensitive to and sequesters. In addition, investigation needs to occur on what type of 
nutrient sensor is being targeted by ESCRTs, whether or not the ESCRTs are 
sequestering transporters/receptors of amino acid sensing or direct targeting to the amino 
acid itself. If the end results are true, ESCRTs are involved in nutrient sensing, this will 
have a dramatic affect in the ESCRT research field and nutrient sensing world. It could 
potentially reformat the function of the different ESCRT complexes, possible adding the 
sequestration function to ESCRT-III responsibility.  It will open new doors by 
uncovering more ESCRT involvement in cellular processes along with their implications 
in the nutrition field and their health impacts.  
For instances, the correlation of Pmr1 and its calcium regulation. Calcium is an 
essential and influential nutrient upon many signaling pathways and is important for 
many cellular processes. The human homolog of Pmr1 is SPCA2. Recent studies show 
that dysregulation of SPCA2 along with the discovery of Orai1 (Ca2+ channel) mediates 
store-independent calcium influx constitutively activates this pathway and promotes the 
activity of tumor cells, specifically the transformation of mammary epithelial cells to 
cancerous cells206. This recent evidence could potential associate the role of ESCRTs and 
its nutrient sensing potential capabilities with tumor development through its association 
of Pmr1 (SPCA2). In summary, this irritates the impact that ESCRTs could have on 
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human health and strengthens the importance of nutrient sensing for proper human 
development. The links between ESCRTs, nutrient signaling, and human health are only 
the just beginning to be uncovered.  
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Figure 15  
 
Figure 15 - Schematic depicting possible locations of ESCRT interaction within the 
EGO pathway communication with TOR. 
Schematic depicting possible ESCRT interaction with the EGO complex. A) ESCRT 
machinery can be the mechanism directly relaying amino acids to the EGO complex to 
TOR pathway. B) ESCRT machinery, non-direct route, can interact with EGO complex 




Figure 16  
 
Figure 16 - Schematic depicting possible locations of ESCRT interactions within 
Pmr1 pathway communication with TOR. 
Schematic depicting possible location of ESCRT mutants within the Pmr1 pathway. Srn2 
and Snf7 maintaining/increasing high TOR activity results can place them at two 
positions, upstream and/or downstream of Pmr1. It is already known that the mutants of 
Srn2 and Snf7, upstream, lead to the decrease expression of pmr1, but according to the 
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Appendix i: Yeast Strains 
 
Contains all strains created and used during any assays and tetrad dissections. This list 
contains both the parent strains, transformed strains, and the substrains (tetrad spores). 
Notes:  
*NT – Not True Tetrad 
MAT? – mating type can’t be distinguished  
 
Name Background Genotype 
WTa BY4741 MATa his3 leu2 ura3 met15 
WTα BY4742 MATalpha his3 leu2 ura3 lys2 
Tester a BY MATa lys1D0 
Tester α BY MATα lys1D0 
∆Whi2_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps27_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆srn2_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps28_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆mvb12_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆snf8_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps36_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆snf7_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps20_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆did4_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps24_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps60_ss1 BY4741 MATa his3 leu2 ura3 met15 
∆vps27 
prATG8[atg8/GFP] BY4741 
MATa his3 leu2 ura3 met15 
vps27::KanMX4 
∆srn2 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 srn2::KanMX4 
∆srn2_6d 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 srn2::KanMX4 
∆snf8 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 snf8::KanMX4 
∆snf7 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 snf7::KanMX4 
WTα 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 
∆Whi2 
prATG8[atg8/GFP] BY4741 MATa his3 leu2 ura3 met15 Whi2:KanMX4 
∆vps27_1a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 
∆vps27_1b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 
∆vps27_1c sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_1d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 vps27::KanMX4 
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∆vps27_2a sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 
∆vps27_2b sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 
∆vps27_2c sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 met15 vps27::KanMX4 
∆vps27_2d sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_3a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 
∆vps27_3b sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 vps27::KanMX4 
∆vps27_3c sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 
∆vps27_3d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_4a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 
∆vps27_4b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 vps27::KanMX4 
∆vps27_4c sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 
∆vps27_4d sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_5a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 met15 
∆vps27_5b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 met15 
∆vps27_5c sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_5d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 vps27::KanMX4 
∆vps27_6a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 
∆vps27_6b sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_6c sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 met15 
∆vps27_6d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_7a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 vps27::KanMX4 
∆vps27_7b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 
∆vps27_7c sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_7d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 met15 
∆vps27_8a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_8b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 met15 
∆vps27_8c sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_8d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 
∆vps27_9a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 
∆vps27_9b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_9c sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 
∆vps27_9d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 vps27::KanMX4 
∆vps27_10a sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 vps27::KanMX4 
∆vps27_10b sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 met15 
∆vps27_10c sporulated from WT BY4742 x ∆vps27 his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_10d sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 lys2 
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∆vps27_11a sporulated from WT BY4742 x ∆vps27 - 
∆vps27_11b sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 lys2 met15 vps27::KanMX4 
∆vps27_11c sporulated from WT BY4742 x ∆vps27 MATalpha his3 leu2 ura3 
∆vps27_11d sporulated from WT BY4742 x ∆vps27 MATa his3 leu2 ura3 met15 
WTα_12a BY4742  MATalpha his3 leu2 ura3 met15 
∆Whi2_12b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 
∆vps27_12c BY4741 MATa his3 leu2 ura3 lys2 vps27::KanMX4 
∆vps28_1a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
∆vps28_1b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_1c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps28_1d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 vps28::KanMX4 
∆vps28_2a*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps28::KanMX4 
∆vps28_2b*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_2c*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_2d*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 
∆vps28_3a*NT sporulated from WT BY4742 x ∆vps28 Did not grow, not true tetrad 
∆vps28_3b*NT sporulated from WT BY4742 x ∆vps28 Did not grow, not true tetrad 
∆vps28_3c*NT sporulated from WT BY4742 x ∆vps28 Did not grow, not true tetrad 
∆vps28_3d*NT sporulated from WT BY4742 x ∆vps28 Did not grow, not true tetrad 
∆vps28_4a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 vps28::KanMX4 
∆vps28_4b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 
∆vps28_4c sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 
∆vps28_4d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_5a*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 
∆vps28_5b*NT sporulated from WT BY4742 x ∆vps28 MAT? his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_5c*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps28_5d*NT sporulated from WT BY4742 x ∆vps28 MAT? his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_6a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_6b 
sporulated from WT BY4742 x *NT 
∆vps28 MATalpha his3 leu2 ura3 lys2 met15 
∆vps28_6c sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps28::KanMX4 
∆vps28_6d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
∆vps28_7a*NT sporulated from WT BY4742 x ∆vps28 MAT? his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_7b*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps28_7c*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
∆vps28_7d*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vps28::KanMX4 
∆vps28_8a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 
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∆vps28_8b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 vps28::KanMX4 
∆vps28_8c sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 
∆vps28_8d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_9a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 vps28::KanMX4 
∆vps28_9b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps28::KanMX4 
∆vps28_9c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 
∆vps28_9d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 
∆vps28_10a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_10b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 vps28::KanMX4 
∆vps28_10c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps28_10d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
∆vps28_11a*NT sporulated from WT BY4742 x ∆vps28 MAT? his3 leu2 ura3 lys2 met15 vps28::KanMX4* 
∆vps28_11b*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps28_11c*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps28_11d*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vps28::KanMX4 
WTα_12a BY4742  MATalpha his3 leu2 ura3 met15 
∆Whi2_12b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 
∆vps28_12c BY4741 MATaxMATalpha his3 leu2 ura3 lys2 met15 vps28::KanMx4 
∆srn2_1a sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 T 
∆srn2_1b sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 srn2::KanMX4T 
∆srn2_1c sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2T 
∆srn2_1d sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 met15 srn2::KanMX4T 
∆srn2_2a*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 met15 srn2::KanMX4 
∆srn2_2b*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 srn2::KanMX4 
∆srn2_2c*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 
∆srn2_2d*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 
∆srn2_3a*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 met15 
∆srn2_3b*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 srn2::KanMX4 
∆srn2_3c*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 
∆srn2_3d*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 srn2::KanMX4 
∆srn2_4a*NT sporulated from WT BY4742 x ∆srn2 MATalpha met15 
∆srn2_4b*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys2 srn2::KanMX4 
∆srn2_4c*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys2 met15 
∆srn2_4d*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 
∆srn2_5a*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 met15 
∆srn2_5b*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 
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∆srn2_5c*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 met15 srn2::KanMX4 
∆srn2_5d*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys2 srn2::KanMX4 
∆srn2_6a sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 met15 T 
∆srn2_6b sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 srn2::KanMX4 T 
∆srn2_6c sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 T 
∆srn2_6d sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 srn2::KanMX4 T 
∆srn2_7a sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 met15 T 
∆srn2_7b sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 srn2::KanMX4 T 
∆srn2_7c sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 met15 srn2::KanMX4 T 
∆srn2_7d sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 T 
∆srn2_8a*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 met15 srn2::KanMX4**NT 
∆srn2_8b*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3  srn2::KanMX4 
∆srn2_8c*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3  lys2 met15 
∆srn2_8d*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3  lys2 
∆srn2_9a*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys2 met15 srn2::KanMX4 
∆srn2_9b*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 srn2::KanMX4 
∆srn2_9c*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 met15 
∆srn2_9d*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys3 met15 srn2::KanMX4 
∆srn2_10a*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 lys2 met15 srn2::KanMX4 
∆srn2_10b*NT sporulated from WT BY4742 x ∆srn2 MAT? his3 leu2 ura3 
∆srn2_10c*NT sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 srn2::KanMX4 
∆srn2_10d*NT sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 
∆srn2_11a sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 srn2::KanMX4 T 
∆srn2_11b sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 lys2 met15 srn2::KanMX4 T 
∆srn2_11c sporulated from WT BY4742 x ∆srn2 MATalpha his3 leu2 ura3 lys2 met15 
∆srn2_11d sporulated from WT BY4742 x ∆srn2 MATa his3 leu2 ura3 
WTα_12a BY4742  MATalpha his3 leu2 ura3 met15 
∆Whi2_12b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 
∆srn2_12c BY4741 MATa his3 leu2 ura3 lys2 srn2::KanMX4 
∆mvb12_1a 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 lys2 met15 
∆mvb12_1b 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 met15 
mvb12::KanMX4 
∆mvb12_1c 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 lys2 mvb12::KanMX4 
∆mvb12_1d 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 
∆mvb12_2a 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_2b 
sporulated from WT BY4742 x 




sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 mvb12::KanMX4 
∆mvb12_2d 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 lys2 met15 
∆mvb12_3a 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_3b 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 lys2 
∆mvb12_3c sporulated from WT BY4742 x ∆mvb12 MATa his3 leu2 ura3 met15 mvb::KanMX4 
∆mvb12_3d sporulated from WT BY4742 x ∆mvb12 MATa his3 leu2 ura3 met15 
∆mvb12_4a 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 
∆mvb12_4b 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 lys2 met15 
∆mvb12_4c 
sporulated from WT BY4742 x 
∆mvb12 
MATa his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_4d 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 mvb12::KanMX4 
∆mvb12_5a 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 met15 
∆mvb12_5b 
sporulated from WT BY4742 x 
∆mvb12 
MATa his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_5c 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 
∆mvb12_5d 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_6a 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_6b 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 met15 
∆mvb12_6c sporulated from WT BY4742 x ∆mvb12 MATa his3 leu2 ura3 
∆mvb12_6d sporulated from WT BY4742 x ∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_7a 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 
∆mvb12_7b 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_7c 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 met15 
mvb12::KanMX4 
∆mvb12_7d 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 lys2 met15 
∆mvb12_8a*NT 
sporulated from WT BY4742 x 
∆mvb12 
MATa his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_8b*NT 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_8c*NT 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 mvb12::KanMX4 
∆mvb12_8d*NT 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 





sporulated from WT BY4742 x 
∆mvb12 MAT? his3 leu2 ura3 lys2 met15 
∆mvb12_9c*NT 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 mvb12::KanMX4 
∆mvb12_9d*NT sporulated from WT BY4742 x ∆mvb12 Did not grow 
∆mvb12_10a sporulated from WT BY4742 x ∆mvb12 
MATa his3 leu2 ura3 lys2 met15 
mvb12::KanMX4 
∆mvb12_10b 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 
∆mvb12_10c 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_10d 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 met15 
mvb12::KanMX4 
∆mvb12_11a 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 met15 
∆mvb12_11b 
sporulated from WT BY4742 x 
∆mvb12 MATa his3 leu2 ura3 lys2 mvb12::KanMX4 
∆mvb12_11c 
sporulated from WT BY4742 x 
∆mvb12 
MATalpha his3 leu2 ura3 lys2 
mvb12::KanMX4 
∆mvb12_11d 
sporulated from WT BY4742 x 
∆mvb12 MATalpha his3 leu2 ura3 met15 
WTα_12a BY4742 MATalpha his3 leu2 ura3 met15 
∆Whi2_12b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 
∆mvb12_12c BY4741 MATa his3 leu2 ura3 lys2 mvb12::KanMX4 
∆snf8_1a sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 snf8::KanMX4 
∆snf8_1b sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_1c sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura2 lys2 met15 
∆snf8_1d sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura2 
∆snf8_2a sporulated from WT BY4742 x ∆snf8 MAT? his3 leu2 ura3 lys2 
∆snf8_2b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_2c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 
∆snf8_2d sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_3a sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 snf8:: KanMX4 
∆snf8_3b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 met15 
∆snf8_3c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_3d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 
∆snf8_4a sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 met15 snf8:: KanMX4 
∆snf8_4b sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 
∆snf8_4c sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_4d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 
∆snf8_5a sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_5b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 snf8:: KanMX4 
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∆snf8_5c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 
∆snf8_5d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 met15 
∆snf8_6a sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 met15 
∆snf8_6b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 met15 
∆snf8_6c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 snf8:: KanMX4 
∆snf8_6d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_7a sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 
∆snf8_7b sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 met15 
∆snf8_7c sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 snf8:: KanMX4 
∆snf8_7d sporulated from WT BY4742 x ∆snf8 Mata his3 leu2 ura3 lys2 met15 snf8:: KanMX4 
∆snf8_8a sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 met15 snf8:: KanMX4 
∆snf8_8b sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 
∆snf8_8c sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 met15 snf8:: KanMX4 
∆snf8_8d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_9a sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 met15 
∆snf8_9b sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_9c sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_9d sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 
∆snf8_10a sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 
∆snf8_10b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_10c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 met15 snf8:: KanMX4 
∆snf8_10d sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 
∆snf8_11a sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 lys2 met15 
∆snf8_11b sporulated from WT BY4742 x ∆snf8 MATa his3 leu2 ura3 met15 
∆snf8_11c sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 lys2 snf8:: KanMX4 
∆snf8_11d sporulated from WT BY4742 x ∆snf8 MATalpha his3 leu2 ura3 snf8:: KanMX4 
WTa_12a BY4741 MATa his3 leu2 ura3 lys2 
∆Whi2_12b BY4741 MATa his3 leu2 ura3  lys2 whi2:: KanMX4 
∆snf8_12c BY4742 x BY4741 MATaXMATalpha his3 leu2 ura3 lys2 met15 snf8::KanMX4 
∆snf7_1a sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 met15 
∆snf7_1b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 met15 
∆snf7_1c sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 snf7::KanMX4 
∆snf7_1d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 snf7::KanMX4 
∆snf7_2a sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 snf7::KanMX4 
∆snf7_2b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 met15 
∆snf7_2c sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 met15 snf7::KanMX4 
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∆snf7_2d sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 
∆snf7_3a sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 
∆snf7_3b sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 snf7::KanMX4 
∆snf7_3c sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys3 met15 
∆snf7_3d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 met15 snf7::KanMX4 
∆snf7_4a sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 
∆snf7_4b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 snf7::KanMX4 
∆snf7_4c sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 met15 snf7::KanMX4 
∆snf7_4d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 met15 
∆snf7_5a sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 
∆snf7_5b sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 
∆snf7_5c sporulated from WT BY4742 x ∆snf7 MAT? His3 leu2 ura3 lys2 met15 snf7::KanMX4 
∆snf7_5d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 met15 snf7::KanMX4 
∆snf7_6a sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 snf7::KanMX4 
∆snf7_6b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 met15 
∆snf7_6c sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 snf7::KanMX4 
∆snf7_6d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 met15 
∆snf7_7a*NT sporulated from WT BY4742 x ∆snf7 MAT? his3 leu2 ura3 lys2 met15 snf7::KanMX4 
∆snf7_7b*NT sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 snf7::KanMX4 
∆snf7_7c*NT sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 met15 
∆snf7_7d*NT sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 met15 snf7::KanMX4 
∆snf7_8a sporulated from WT BY4742 x ∆snf7 MATalpa his3 leu2 ura3 met15 snf7::KanMX4 
∆snf7_8b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 
∆snf7_8c sporulated from WT BY4742 x ∆snf7 MATalpha his3 lue2 ura3 met15 snf7::KanMX4 
∆snf7_8d sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 
∆snf7_9a sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 snf7::KanMX4 
∆snf7_9b sporulated from WT BY4742 x ∆snf7 MATa his3 leu2 ura3 lys2 met15 snf7::KanMX4 
∆snf7_9c sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 lys2 met15 
∆snf7_9d sporulated from WT BY4742 x ∆snf7 MATalpha his3 leu2 ura3 
WTα_10a* BY4742 MATa his3 leu2 ura3 lys2* 
∆Whi2_10b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 
∆snf7_10c BY4742 x BY4741 MATaxMATalpha his3 leu2 ura3 lys2 met15 snf7::KanMX4 
WTα_11b BY4742 MATalpha his3 leu2 ura3 met15 
∆Whi2_11a BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 




∆did4_1b*NT sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 
∆did4_1c*NT sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 lys2 did4::KanMX4 
∆did4_1d*NT sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 met15 
∆did4_2a sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 
∆did4_2b sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 lys2 met15 did4:KanMX4 
∆did4_2c sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 did4:KanMX4 
∆did4_2d sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 met15 
∆did4_3a*NT sporulated from WT BY4742 x ∆did4 
MATa his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_3b*NT sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 
did4::KanMX4 
∆did4_3c*NT sporulated from WT BY4742 x ∆did4 
MATa his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_3d*NT sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 met15 
∆did4_4a*NT sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 did4::KanMX4 
∆did4_4b*NT sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_4c*NT sporulated from WT BY4742 x ∆did4 
MATa his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_4d*NT sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 
∆did4_5a sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 
∆did4_5b sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 met15 
did4::KanMX4 
∆did4_5c sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 
∆did4_5d sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 met15 
did::KanMX4 
∆did4_6a sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 
∆did4_6b sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 
did4::KanMX4 
∆did4_6c sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 met15 
∆did4_6d sporulated from WT BY4742 x ∆did4 
MATa his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_7a sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 met15 
∆did4_7b sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 did4::KanMX4 
∆did4_7c sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 met15 
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∆did4_7d sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 
did4::KanMX4 
∆did4_8a sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 
∆did4_8b sporulated from WT BY4742 x ∆did4 MATalpha his3 leu2 ura3 did4::KanMX4 
∆did4_8c sporulated from WT BY4742 x ∆did4 
MATalpha his3 leu2 ura3 lys2 met15 
did4::KanMX4 
∆did4_8d sporulated from WT BY4742 x ∆did4 MATa his3 leu2 ura3 lys2 met15 
WTα_9a BY4742 MATa his3 leu2 ura3 lys2 
∆Whi2_9b BY4741 MATa his3 leu2 ura3 lys2 whi2::KanMX4 
∆did4_9c BY4742 x BY4741 
MATaXMATalpha his2 leu2 ura3 lys2 
met15 did4::KanMX4 
WTα_10a BY4742 MATalpha his3 leu2 ura3 met15 
∆Whi2_10b BY4741 MATa his3 leu2 ura3 lys2 whi2::KanMX4 
∆vps4_1a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
∆vps4_1b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps4::KanMX4 
∆vps4_1c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps4::KanMX4 
∆vps4_1d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 
∆vps4_2a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 
∆vps4_2b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 vps4::KanMX4 
∆vps4_2c sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 
∆vps4_2d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 vps4::KanMX4 
∆vps4_3a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps4_3b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 
∆vps4_3c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 vps4::KanMX4 
∆vps4_3d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vps4::KanMX4 
∆vps4_4a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vps4:KanMX4 
∆vps4_4b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 vps4:KanMX4 
∆vps4_4c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 
∆vps4_4d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 
∆vps4_5a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 
∆vps4_5b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 vps4::KanMX4 
∆vps4_5c sporulated from WT BY4742 x ∆vps28 MATalphs his3 leu2 ura3 lys2 
∆vps4_5d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vps4::KanMX4 
∆vps4_6a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 
∆vps4_6b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 vps4::KanMX4 
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∆vps4_6c sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 vsp4::KanMX4 
∆vps4_6d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 
∆vps4_7a*NT sporulated from WT BY4742 x ∆vps28 MAT? his3 leu2 ura3 lys2 met15 vps4::KanMX4 
∆vps4_7b*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 met15 vps4:KanMX4 
∆vps4_7c*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 vps4::KanMX4 
∆vps4_7d*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 
∆vps4_8a sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 vps4::KanMX4 
∆vps4_8b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 uar3 lys2 met15 
∆vps4_8c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps4_8d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps4::KanMX4 
∆vps4_9a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps4::KanMX4 
∆vps4_9b sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps4_9c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 vps4::KanMX4 
∆vps4_9d sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 
∆vps4_10a sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 met15 vps4::KanMX4 
∆vps4_10b sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 vps4::KanMX4 
∆vps4_10c sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 lys2 
∆vps4_10d sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps4_11a*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 lys2 vps4::KanMX4 
∆vps4_11b*NT sporulated from WT BY4742 x ∆vps28 MATalpha his3 leu2 ura3 met15 
∆vps4_11c*NT sporulated from WT BY4742 x ∆vps28 did not grow 
∆vps4_11d*NT sporulated from WT BY4742 x ∆vps28 MATa his3 leu2 ura3 met15 
WTα_12a BY4742 MATalpha his3 leu2 ura3 met15 
∆Whi2_12b BY4741 MATa his3 leu2 ura3 lys2 Whi2::KanMX4 






Appendix ii: Raw Tetrad Data 
 
Contains raw tetrad data of the characteristic analysis and phenotype analysis compiled from 
this study. Tetrad dissection methods can be found in Chapter 2 (Methods) and the 
abbreviations are listed below. Tetrads were performed backcrossing with wild type α 
(BY4742 MATα). Controls for each tetrad analysis are WT (BY4741 MATa) or WT (28B) 
(BY4742 MATα),  ∆whi2, and parental strain (haploid or diploid).  
 
Abbreviation   
MAT Mating type 
LYS2 Presence of LYS2 
MAT15 Presence of MET15 
KAN Presence of KanMX knockout indicator 
HR Heat ramp assay (Cell death) 
LAA Low amino acid assay 
LAA + (5nM or 2.5nM) Rap Rapamycin assay 




LAA+5nMRap* -  analysis discrepancies based on poor growth on 5nM concentration of 
rapamycin 
*NT - not true tetrad 
tetrad spore viability MAT LYS2 MET15 KAN HR LAA LAA+2.5nMRap OD 
1 a m a  +  ++++ + + 0.745 
 b m alpha    ++++ + + 0.731 
 c m a + + + +++ ++++ ++++ 0.751 
 d m alpha +  + +++ ++++ ++++ 0.743 
           2 a m alpha +   ++++ + + 0.856 
 b m a    ++++ + + 0.771 
 c m alpha  + + +++ ++++ ++++ 0.889 
 d m a + + + +++ ++++ ++++ 0.846 
           3 a m a +   ++++ + + 0.718 
 b m a  + + +++ ++++ ++++ 0.773 
 c m alpha    ++++ + + 0.743 
 d m alpha + + + +++ ++++ ++++ 0.745 
           4 a m a  +  ++++ + + 0.764 
 
b m alpha +  + +++ ++++ ++++ 0.722 c m alpha +   ++++ + + 0.802 d m a   + +++ ++++ ++++ 0.736 
           5 a m a + +  ++++ + + 0.791 
 b m alpha  +  ++++ + + 0.920 
 c m a   + +++ ++++ ++++ 0.835 
 d m alpha +  + +++ ++++ ++++ 0.811 
           6 a m a +   ++++ + + 0.734 
 b m a   + +++ ++++ ++++ 0.784 
 c m alpha  +  ++++ + + 0.781 
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 d m alpha + + + +++ ++++ ++++ 1.133 
           7 a m a  + + +++ ++++ ++++ 0.857 
 b m alpha +   ++++ + + 0.715 
 c m a   + +++ ++++ ++++ 0.913 
 d m alpha + +  ++++ + + 0.721 
           8 a m a + + + +++ ++++ ++++ 0.765 
 b m alpha + +  ++++ + + 0.699 
 c m a   + +++ ++++ ++++ 0.882 
 d m alpha    ++++ + + 0.654 
           9 a m a +   ++++ + + 0.827 
 b m alpha + + + +++ ++++ ++++ 0.711 
 c m a  +  ++++ + + 0.904 
 d m alpha   + +++ ++++ ++++ 0.717 
           10*NT a Not recorded a   + - +++ - 0.465 
 b Not recorded alpha  +  ++++ - + 0.721 
 c Not recorded - + + + +++ + +++ 0.841 
 d Not recorded alpha +   ++++ ++ + 0.754 
           
11*NT a Not recorded -    - - - 
-
0.007 
 b Not recorded a + + + ++++ ++++ ++++ 0.067 
 c Not recorded alpha    ++++ + ++ 0.928 
 d Not recorded a  +  ++++ + +++ 1.011 
           C a WT 28B alpha  +  ++++ + + 0.779 
 b whi2 a +  + + ++++ - 0.698 
 c gene of I a +  + +++ ++++ ++++ 0.842 
           
  * * * * * * * *   
∆mvb12 
Notes: 
viability* - not recorded  
LAA+5nMRap* -  analysis discrepancies based on poor growth on 5nM concentration of rapamycin  
*NT - not true tetrad 




ot available at this tim
e  
1 a  alpha + +  ++++ + - 
 
b  alpha  + + ++ +++ + 
 
c  a +  + ++ +++ + 
 
d  a    ++++ + -                     
2 a  alpha + + + + +++ + 
 
b  a    ++  -  - 
 
c  a   + + +++ + 
 
d  alpha + +  ++  - -                     
3 a  alpha  +  + ++ +++ + 
 
b  alpha  +   +++ +++ - 
 
c  a  + + ++ +++ + 
 
d  a  +  +++ + -                     




b  a + +  +++ + ? c  a + + + ++ +++ ? d  alpha   + ++ +++ ?                     
5 a  alpha  +  ++++ + - 
 
b  a + + + ++ +++ + 
 
c  a    +++ + - 
 
d  alpha +  + ++ +++ +                     
6 a  alpha + + + +++ +++ + 
 
b  a  +  ++++ + - 
 
c  a    ++++ + - 
 
d  alpha +  + ++ +++ +                     
7 a  a    ++++ + - 
 
b  alpha +  + +++ ++ + 
 
c  alpha  + + +++ ++ + 
 
d  a + +  ++++ + -                     
8*NT a  a + + + + + - 
 b  alpha + + + ++ +++ + 
 
c  a   + ++ +++ + 
 
d  alpha    + + -                     
9*NT a  alpha    ++++ + - 
 
b  alpha + +  ++++ + - 
 
c  a   + +++ +++ + 
 
d  both     - _ -                     
10 a  a + + + ++ +++ ? 
 
b  a    +++ + ? 
 c  alpha +  + ++ +++ ? 
 
d  alpha  +  +++ + ?                     
11 a  a  +  ++++ + ? 
 
b  a +  + +++ +++ ? 
 
c  alpha +  + +++ +++ ? 
 d  alpha  +  ++++ + ?                     
C a WT 28B alpha  +  ++++ + + 
 
b whi2  a +  + + ++++ - 
 
c gene of I a + 
 
+ +++ +++ + 
 
d 





viability* - not recorded  
LAA+5nMRap* -  analysis discrepancies based on poor growth on 5nM concentration of rapamycin  
*NT - not true tetrad 
  
tetrad spore viability* MAT LYS2 MET15 KAN HR LAA LAA+5nMRap* OD 
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1 a  a    ++++ + - 1.133 
 
b  alpha + + + ++++ +++ + 1.006 
 
c  alpha +   ++++ + - 1.003 
 
d  a  + + ++++ +++ + 1.140                       
2 *NT a  a  + + +++/+ +++ + 0.977 
 
b  alpha + + + + + - 0.964 
 
c  alpha + +  ++++ + + 1.019 
 
d  a +   +++/+ + - 1.039                       
3*NT a  a  +  ++++ + - 1.013 
 
b  alpha + + + +++ +++ + 0.993 
 
c  a/alpha    ++++ + - 1.019 
 
d  a +  + +++ +++ + 1.034                       
4*NT a  alpha  +  ++++ + + 1.027 
 
b  a/alpha +  + +++ +++ - 1.083 
 
c  a/alpha + +  ++++ + - 1.027 
 
d  a    ++++ + + 1.064                       
5*NT a  alpha  +  ++++ + - 1.166 
 
b  a +   +++ + - 1.043 
 
c  a  + + +++ +++ - 1.062 
 
d  a?/alpha +  + ++ +++ + 0.985                       
6 a  a + +  ++++ + - 1.035 
 
b  alpha   + ++ +++ + 0.981 
 
c  alpha + +  ++++ + - 0.993 
 
d  a   + ++ +++ + 1.021                       
7 a  alpha  +  ++++ + - 0.990 
 
b  alpha   + +++ +++ + 1.014 
 
c  a + + + ++++ +++ + 1.000 
 
d  a +   ++++ + - 1.059                       
8*NT a  a/alpha  + + ++++ +++ - 1.042 
 
b  a   + +++ +++ + 1.015 
 
c  alpha + +  ++++ + - 1.026 
 
d  a +   ++++ ++ + 1.038                       
9*NT a   alpha + + + ++ + + 0.991 
 
b  alpha   + +++ +++ + 0.961 
 
c  a + +  ++++ + - 1.065 
 
d  a/alpha + + + +++ +++ - 1.080                       
10*NT a  alpha/a + + + ++ + + 1.031 
 
b  a/alpha    ++++ + + 1.075 
 
c  a +  + +++ +++ - 1.066 
 
d  alpha + +  ++++ + - 1.033                       
11 a  alpha   + +++ +++ + 1.040 
 
b  a + + + ++++ +++ + 1.008 
 
c  alpha + +  ++++ + - 1.027 
 
d  a    ++++ + - 1.082                       




b whi2  a +  + - ++++ - 1.168 
 
c gene of I a + 
 
+ ++ +++ + 0.984 
               * * * * * * * *   
 
           
        ∆vps28 
Notes:  
LAA + 5nMRap* - analysis discrepancies based on poor growth on 5nM concentration of rapamycin 
*NT – not a true tetrad 
tetrad spore viability MAT LYS2 MET15 KAN HR LAA LAA+5nMRap* OD 
1 a m a  +  +++ + - 0.948 
 b s a + + + +++ ++++ + 0.992 
 c m alpha +   ++++ + - 0.983 
 d s alpha   + +++ +++ + 0.911                       
2 a s a   + ++++ ++++ + 0.923 
 b m a + + + ++++ + - 0.972 
 c s alpha +  + +++ ++++ - 0.967 
 d m alpha + +  ++++ + + 0.924                       
3 a dot a - - - - - - 0.009 
 b dot alpha - - - - + + 0.126 
 c dot n/a - - - - - - 0.002 
 d dot n/a - - - - - + 0.000                       
4 a s alpha  + + +++ ++++ + 0.869 
 b m a    ++++ + - 0.915 
 c m a + +  ++++ + - 0.898 
 d s alpha +  + +++ ++++ + 0.945                       
5*NT a m alpha + +  ++++ + + 0.909 
 b L ? + + + ++++ + - 0.963 
 c m alpha  +  ++++ + - 0.924 
 d s a +  + +++ ++++ + 1.115                       
6 a s alpha +  + +++ ++++ + 0.933 
 b m alpha + +  ++++ + - 0.909 
 c s a   + +++ ++++ + 0.882 
 d m a  +  ++++  - 0.942                       
7*NT a m n/a + + + +++ - - 0.893 
 b s alpha +   +++ + - 0.934 
 c m a  +  ++++ + - 0.913 
 d s a  + + ++++ +++ + 0.965                       
8 a m a    ++++ + - 1.015 
 b s alpha  + + +++ ++++ + 0.914 
 c m a +   ++++ + - 0.936 
 d s alpha + + + +++ ++++ + 0.968                       
9 a s a + + + +++ ++++ + 0.944 
 b s a   + +++ ++++ + 0.912 
 c m alpha    ++++ - - 0.915 
 d m alpha + +  ++++ - - 0.956 
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10 a s alpha +  + +++ ++++ + 0.964 
 b s a +  + +++ ++++ + 0.912 
 c m alpha  +  ++++ + - 0.907 
 d m a  +  ++++ + - 1.090                       
11*NT a m n/a + + + ++++ ? - 0.958 
 b s alpha +   ++++ + - 0.886 
 c s alpha  +  +++ ++++ + 0.904 
 d m a  + + ++++ + - 1.117                       
C a WT 28B alpha  +   +++  + ?  
 b whi2  a +  +  + 
 
++++ ?  
diploid  c gene of I both + + + - + ?  




LAA + 5nMRap* - analysis discrepancies based on poor growth on 5nM concentration of rapamycin 
*NT – not a true tetrad 
tetrad spore viability MAT LYS2 MET15 KAN HR LAA LAA+5nMRap OD 
1 a s alpha  + + +++ ++++ + 0.945 
 b s alpha +  + +++ ++++ + 0.926 
 c m a + +  ++++ + - 1.029 
 d m a    ++++ + - 1.041                       
2 a m - +   ++++ + - 1.011 
 b s a  + + +++ ++++ + 0.923 
 c m alpha  +  ++++ + - 1.023 
 d s a +  + +++ ++++ + 1.013                       
3 a s a   + +++ ++++ + 0.9 
 b m a + +  ++++ + - 0.926 
 c s alpha +  + +++ ++++ + 0.893 
 d m alpha  +  ++++ + - 1.052                       
4 a m a (very faint) + + + ++++ + - 0.995 
 b m alpha    ++++ + - 1.022 
 c s a  + + +++ ++++ + 0.943 
 d s alpha +   +++ + + 1.004                       
5 a s a  + + +++ ++++ + 0.97 
 b s a   + +++ ++++ + 0.959 
 c m alpha +   ++++ + - 1.009 
 d m alpha + +  ++++ + - 1.037                       
6 a m alpha + +  ++++ + - 0.978 
 b m a  +  ++++ + - 0.976 
 c s alpha   + +++ ++++ + 1 
 d s alpha +  + +++ ++++ + 0.987                       
7 a m alpha    ++++ + - 0.933 
 b m alpha + +  ++++ + - 1 
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 c s a   + +++ ++++ + 0.95 
 d s a + + + +++ ++++ + 1.126                       
8 a m a + + + +++ ++++ + 1.042 
 b m alpha    ++++ + - 0.998 
 c m a +   ++++ + - 1.061 
 d s alpha  + + +++ ++++ + 1.045                       
9 a m alpha + +  ++++ + - 1.042 
 b s alpha  + + +++ ++++ + 0.983 
 c s a +  + +++ ++++ + 1.047 
 d m a    ++++ + - 1.061                       
10 a m alpha  +  ++++ + - 1.006 
 b s a +  + +++ ++++ + 1.001 
 c s alpha  + + +++ ++++ + 1.019 
 d m a +   ++++ + - 1.099                       
11 a m a + +  ++++ + - 1.048 
 b m a  +  ++++ + - 1.015 
 c s alpha +  + +++ ++++ + 1.043 
 d s alpha   + +++ ++++ + 1.067                       
C a WT a a +   ++++  + ? 1.009 
 b whi2  a +  + +++ 
 
++++ ? 1.031 
 c snf8 a + + + +++ + ? 0.969 




LAA + 5nMRap* - analysis discrepancies based on poor growth on 5nM concentration of rapamycin 
*NT – not a true tetrad 
tetrad spore viability MAT LYS2 MET15 KAN HR LAA LAA+5nMRap* OD 
1 a m alpha + +  ++++ + - 0.889 
 b L a  +  ++++ + - 0.881 
 c s a +  + +++ +++ + 0.882 
 d s alpha   
+ +++ +++ + 0.816 
                      
2 a s alpha +  + +++ +++ + 0.937 
 b m a + +  ++++ + - 0.989 
 c s alpha  + + +++ +++ + 0.945 
 d m a    ++++ + - 0.992                       
3 a m a    ++++ + - 1.030 
 b s alpha +  + +++ ++++ + 1.100 
 c m a + +  ++++ + - 1.267 
 d s alpha  + + +++ ++++ + 0.943                       
4 a m alpha +   ++++ + - 1.156 
 b s a   + +++ ++++ + 0.948 
 c s a + + + +++ ++++ + 1.051 
 d m alpha  +  ++++ + - 0.932                       
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5 a m a +   ++++ + - 1.034 
 b m alpha +   ++++ + - 0.950 
 c m - + + + +++ + - 1.002 
 d s alpha  + + +++ ++++ + 0.940                       
6 a s a   + +++ ++++ + 1.007 
 b m a  +  ++++ + - 0.975 
 c s alpha  +  + +++ ++++ + 0.963 
 d m alpha  + +  ++++ + - 1.077                       
7 a L - + + + ++++ + - 0.860 
 b s alpha   + +++ ++++ + 1.022 
 c L a  +  ++++ + - 0.954 
 d s a + + + +++ ++++ + 1.056                       
8 a s alpha  + + +++ ++++ + 1.081 
 b m a +   ++++ + - 1.012 
 c s alpha  + + +++ ++++ + 0.977 
 d m a +   ++++ + - 1.164                       
9 a s a   + +++ ++++ + 1.023 
 b s a + + + +++ ++++ + 1.102 
 c m alpha + +  ++++ + - 1.211 
 d m alpha    ++++ + - 1.160                       
C a WT a a +   ++++ + - 1.036 
 b whi2 a +  + +++ ++++ - 0.993 
 c gene of I  n/a + + + ++ + - 0.952 
         - 0.000                       
C b WT 28B alpha  +  ++++  + - 1.166 
 a whi2  a +  + +++ 
 
++++ - 0.949 




LAA + 5nMRap* - analysis discrepancies based on poor growth on 5nM concentration of rapamycin 
*NT – not a true tetrad 
did4 analysis 
tetrad  viability MAT LYS2 MET15 KAN HR LAA LAA+2.5nMRap OD  
1*NT a m alpha + + + +++ + - 0.737 
 b s a +   ++++ + - 0.800 
 c s alpha +  + +++ ++++ + 0.885 
 d m a  +  ++++ + - 0.824 
                      
2 a m a +   ++++ + - 0.816 
 b xs alpha + + + +++ ++++ + 1.037 
 c s a   + +++ ++++ + 0.935 
 d m alpha  +  ++++ + - 0.862 
                      
3*NT a m a + + + +++ + - 0.825 
113 
 
 b s alpha +  + +++ ++++ + 0.922 
 c m a + + + +++ ++++ + 0.907 
 d m alpha  +  ++++ + - 0.819 
                      
4*NT a s alpha   + +++ ++++ + 0.896 
 
b m alpha + + + ++++ + - 0.877 
 
c s a + + + +++ ++++ + 0.927 
 
d m a +   ++++ + - 0.832 
                      
5 a m a +   ++++ + - 1.071 
 b xs alpha  + + +++ ++++ + 1.080 
 c m a    +++ ++++ + 1.095 
 d s alpha + + + ++++ + - 0.841 
                      
6 a m alpha    ++++ + - 0.807 
 b xs alpha +  + +++ ++++ + 0.874 
 c m a  +  ++++ + - 0.846 
 d s a + + + +++ ++++ + 1.082 
                      
7 a s a  +  ++++ + - 0.955 
 b xs alpha   + +++ ++++ + 0.881 
 c m a + +  ++++ + - 0.810 
 d s alpha +  + +++ ++++ + 1.072 
                      
8 a m a    ++++ + - 0.903 
 b xs alpha   + +++ ++++ + 0.863 
 c xs alpha + + + +++ ++++ + 0.941 
 d m a + +  ++++ + - 0.977 
                      
C1 a WT a a +   ++++ + - 0.794 
 
b whi2  a +  + ++ ++++ - 0.899 
 
c did4 (diploid) a/alpha + + + +++ + - 0.936 
  
         
                      
C2 a WT a alpha  +  ++++ + - 0.854 
 b whi2  a +  + +++ ++++ - 1.113 
  
 
        
           










LAA + 5nMRap* - analysis discrepancies based on poor growth on 5nM concentration of rapamycin 
*NT – not a true tetrad 
tetrad spore viability MAT LYS2 MET15 KAN HR LAA LAA+2.5nMRap OD  
1 a m a  +  ++++ + + 0.705 
 b m alpha   + +++ ++++ ++++ 0.708 
 c m alpha +  + +++ ++++ ++++ 0.690 
 d m a + +  ++++ + + 0.672 
           2 a m alpha    ++++ ++ + 0.707 
 b m alpha  + + +++ ++++ ++++ 0.695 
 c m a +   ++++ + + 0.715 
 d m a + + + +++ ++++ ++++ 0.761 
           3 a m alpha +   ++++ + + 0.745 
 b m a    ++++ + + 0.734 
 c m alpha + + + +++ ++++ ++++ 0.724 
 d m a  + + +++ ++++ ++++ 0.757 
       
1:50 dilution 
   4 a m a  + + +++ ++++ ++++ 0.745 
 b m alpha + + + ++ ++++ ++++ 0.729 
 c m alpha    ++ + + 0.714 
 d m a +   +++ + + 0.737 
           5 a m a +   ++++ + + 0.775 
 b s alpha  + + +++ ++++ ++++ 0.688 
 c m alpha +   ++++ + + 0.718 
 d m a  + + +++ ++++ ++++ 0.694 
           6 a m a +   ++++ + + 0.731 
 b m alpha   + +++ ++++ ++++ 0.700 
 c m a  + + +++ ++++ ++++ 0.698 
 d m alpha + +  ++++ + + 0.772 
           7*NT a m a/alpha + + + ++ + - 0.621 
 b m alpha + + + ++++ ++++ ++++ 0.614 
 c m a +  + ++++ ++++ ++++ 0.638 
 d m alpha    ++++ + + 0.691 
           8 a m alpha +  + ++ ++++ ++++ 0.701 
 b m a + +  ++++ + + 0.713 
 c m alpha  +  ++++ + + 0.700 
 d m a   + ++++ ++++ ++++ 0.730 
           9 a m a   + ++++ ++++ ++++ 0.766 
 b m alpha +   +++ + + 0.751 
 c m alpha  + + +++ ++++ ++++ 0.731 
 d m a + +  ++++ + + 0.746 
       
1:50 dilution 
   10 a m a + + + +++ ++++ ++++ 0.728 
 b m a   + +++ ++++ ++++ 0.731 
 c m alpha +   ++++ + + 0.734 
 d m alpha  +  ++++ + + 0.706 
           11*NT a m a +  + +++ ++++ ++++ 0.771 
 b m alpha  +  ++++ + + 0.737 
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 c - n/a    - - - 
-
0.004 
 d m a  +  ++++ + ++ 0.800 
           C a WT  alpha  +  ++++ + + 0.830 
 b whi2 a +  + + ++++ + 0.747 
 c vps4 a +  + +++ ++++ +++ 0.618 
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